WO2014049887A1 - Puncture device and medical fluid application device - Google Patents

Puncture device and medical fluid application device Download PDF

Info

Publication number
WO2014049887A1
WO2014049887A1 PCT/JP2012/075874 JP2012075874W WO2014049887A1 WO 2014049887 A1 WO2014049887 A1 WO 2014049887A1 JP 2012075874 W JP2012075874 W JP 2012075874W WO 2014049887 A1 WO2014049887 A1 WO 2014049887A1
Authority
WO
WIPO (PCT)
Prior art keywords
needle
outer needle
puncture
inner needle
slide
Prior art date
Application number
PCT/JP2012/075874
Other languages
French (fr)
Japanese (ja)
Inventor
内山 城司
近藤 晃
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to PCT/JP2012/075874 priority Critical patent/WO2014049887A1/en
Publication of WO2014049887A1 publication Critical patent/WO2014049887A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1583Needle extractors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1585Needle inserters

Definitions

  • the present invention relates to a puncture device and a drug solution administration device, and is suitable for application when, for example, insulin is administered into the body.
  • a device that administers medicinal solution it is a portable device that is used by adhering to the user's skin and is administered into the body by pushing out the medicinal solution filled in the outer cylinder through a plunger.
  • a so-called syringe pump type drug administration device has been proposed (see, for example, Patent Document 1).
  • a chemical solution administration device a chemical solution is administered through a puncture needle that is punctured into a user's body.
  • a puncture needle a metal inner needle and a plastic outer needle are used as a structure of this puncture needle are used.
  • a double-structured puncture needle is proposed (see, for example, Patent Document 2).
  • This double puncture needle is inserted into the user's body with the metal inner needle protruding from the tip of the plastic outer needle, and then the metal inner needle is the plastic outer needle.
  • the drug solution is administered through the outer needle in a state where only the outer needle is removed from the body and is left in the body of the user.
  • the conventional double-structured puncture needle it is made to function as an indwelling needle which indwells an outer needle in a user's body. If the diameter of the indwelling needle is reduced, the pain of the user can be reduced.
  • a metal inner needle is inserted inside the outer needle as the indwelling needle. The inner diameter of the outer needle had to be larger than the outer diameter of the metal inner needle, and it was difficult to reduce the diameter of the indwelling needle.
  • a puncture needle having an indwelling needle as an indwelling needle instead of an outer needle can be realized, the diameter of the indwelling needle can be easily reduced as compared to a conventional puncture needle using the outer needle as an indwelling needle, and the burden on the user is reduced. It is thought that this can be further reduced.
  • a new puncture mechanism is required for extracting only the outer needle while the inner needle is left in the user's body, and this new puncture mechanism is also simplified. It is required to ensure that the puncture needle can be punctured with a simple configuration.
  • the present invention has been made in consideration of the above points, and proposes a puncture device and a drug solution administration device capable of reliably puncturing a double puncture needle having an inner needle as an indwelling needle with a simple configuration. It is what.
  • a puncture mechanism that pulls back only the outer needle of the puncture needle into the housing while the inner needle is left in the body, and the puncture mechanism includes a pusher that can be pushed into the housing; and An outer needle slide portion having the outer needle that can slide in the housing portion, a fixing release portion that fixes or releases the pushing portion and the outer needle slide portion, and one end fixed to the housing portion And an elastic member whose other end is fixed to the outer needle slide portion and one end of the pushing portion The other end is fixed to the rear end portion of the inner needle, and has an inner needle pulling portion that pulls the inner needle as the pressing portion is pushed, and the pushing portion and the outer needle sliding portion When the push-in portion is pushed in with the fixed release portion being fixed, the outer needle slide portion slides in one direction and the inner needle is pulled by the inner needle pulling portion.
  • the fixing release portion causes the push portion and the outer needle slide portion to The fixation was released, and only the outer needle slide portion was slid in the other direction by the elastic member, and only the outer needle was pulled back into the housing portion while the inner needle was left in the body.
  • a puncture needle having a double structure of an outer needle and an inner needle inserted into the outer needle, a housing portion for storing the puncture needle, and a housing portion
  • the puncture needle with the tip of the inner needle inserted into the outer needle is protruded from the housing and punctured into the body of the user, and the inner needle of the puncture needle
  • a puncture mechanism that can be pushed into the casing, and an outer needle that is slidable within the casing and has the outer needle.
  • a fixing part for fixing or releasing the sliding part, and the pushing part and the outer needle sliding part One end is fixed to the housing part and the other end is fixed to the outer needle slide part, and one end is fixed to the pushing part and the other end is fixed to the rear end part of the inner needle.
  • An inner needle pulling portion that pulls the inner needle as the pushing portion is pushed, and the pushing portion is pushed in a state where the pushing portion and the outer needle slide portion are fixed by the fixing release portion.
  • the fixation release portion releases the fixation between the push-in portion and the outer needle slide portion, and the elastic member removes only the outer needle slide portion. Slide in direction Te, while the inner needle was indwelled in the body, and to retract only the outer needle in the housing portion.
  • the mechanism that can perform from the puncture of the puncture needle to the return of the outer needle can be performed only by pushing the push portion, and for example, the configuration of the puncture mechanism is simplified without the need for a separate drive portion or the like.
  • the outer needle slide part slides as the pushing part is pushed, and the inner needle pulling part pulls the inner needle, so that the inner needle together with the outer needle can be reliably punctured into the user's body.
  • a mechanism that can perform from the puncture of the puncture needle to the retraction of the outer needle only by the pushing operation with respect to the push-in portion does not require a separate drive unit, and the configuration of the puncture mechanism
  • the outer needle slide part slides as the push-in part is pushed in, and the inner needle pulling part pulls the inner needle, so that the inner needle together with the outer needle is securely punctured into the user's body.
  • FIG. 1 is a schematic diagram illustrating a configuration of a drug solution administration device.
  • FIG. 2 is an exploded perspective view of the chemical liquid administration device.
  • FIG. 3 is a schematic diagram illustrating a configuration of a chemical solution storage unit.
  • FIG. 4 is a schematic diagram illustrating the configuration of the sending unit.
  • FIG. 5 is a schematic diagram showing a state of the piston moved to the pressing position.
  • FIG. 6 is a schematic diagram illustrating the configuration of the drive unit.
  • FIG. 7 is a schematic diagram illustrating the configuration of the drive unit.
  • FIG. 8 is a schematic diagram illustrating a configuration of a delivery unit and a drive unit including a film.
  • FIG. 9 is a schematic diagram showing the configuration of the puncture mechanism.
  • FIG. 10 is a schematic diagram showing the configuration of the puncture mechanism.
  • FIG. 11 is a schematic diagram illustrating the configuration of the base.
  • FIG. 12 is a schematic diagram illustrating the configuration of the inner needle fixing portion.
  • FIG. 13 is a schematic diagram illustrating the configuration of the central portion.
  • FIG. 14 is a schematic diagram for explaining the operation of the puncture mechanism.
  • FIG. 15 is a schematic diagram for explaining the return of the outer needle by the coil spring.
  • FIG. 16 is a schematic diagram for explaining the operation of the puncture mechanism.
  • FIG. 17 is a schematic diagram for explaining the operation of the puncture mechanism.
  • FIG. 18 is a schematic diagram for explaining the operation of the puncture mechanism.
  • FIG. 19 is a schematic diagram showing a configuration of a puncture needle (outer needle + inner needle).
  • FIG. 20 is a schematic diagram illustrating an electrical configuration of the drug solution administration device.
  • FIG. 21 is a schematic diagram illustrating a configuration of a sensor device according to another embodiment.
  • FIG. 22 is a schematic diagram illustrating a configuration of a puncture
  • the drug solution administration device 1 is a portable device that is used by being attached to the skin of a user, and is a bottom device that is open on the upper side and has a space inside.
  • a flat, substantially rectangular parallelepiped shape is formed by the casing 2 and the upper casing 3 that fits into the opening of the lower casing 2.
  • the size of the drug solution administration device 1 may be reduced to such an extent that it can be affixed to the user's skin, and examples thereof include a substantially rectangular parallelepiped shape having a width of 32 mm, a length of 44 mm, and a height of 11 mm.
  • the lower housing part 2 is provided with a sticking part 4 made of double-sided tape or the like on the bottom surface 2A.
  • the medicinal-solution administration device 1 is held by the user when the affixing portion 4 is affixed to the user's skin.
  • the medicinal-solution administration device 1 is a puncture needle (not shown) that is punctured into the user's body in order to administer insulin filled therein to the front end of the bottom surface 2A of the lower housing part 2.
  • the puncture needle has a double structure including a metal outer needle and a resin inner needle, which will be described in detail later.
  • the medicinal solution administration device 1 is provided with a pushing portion 5 ⁇ / b> A capable of pushing operation at the front end of the upper housing portion 3.
  • the pushing portion 5A is a part of the puncture mechanism 5 shown in FIG. 2, and the drug solution administration device 1 is punctured from the puncture needle hole 2B by operating the puncture mechanism 5 when the push portion 5A is pushed into the user.
  • the puncture needle is punctured into the user's body by protruding the needle.
  • the chemical solution administration device 1 is provided with a chemical solution storage unit 6, a flow channel unit 7, a delivery unit 8, a drive unit 9, a substrate unit 10, and the like in a space formed by the lower casing unit 2 and the upper casing unit 3. .
  • the chemical solution storage unit 6 is filled with a chemical solution from the outside in a cylindrical outer cylinder 11.
  • the flow path part 7 includes suction pipes 7A, a delivery pipe 7B, flow paths 22B, 23A, 24A formed in the delivery part 8 and an inner needle of a puncture needle of the puncture mechanism 5, and a chemical solution from the drug solution storage part 6 to the body. Forms a flow path through which.
  • the suction pipe 7A allows the chemical solution storage unit 6 and the flow path 23A formed in the delivery unit 8 to communicate with each other.
  • the delivery tube 7B allows the flow path 24A formed in the delivery unit 8 to communicate with the inner needle of the puncture needle of the puncture mechanism 5.
  • the delivery unit 8 allows the chemical solution stored in the chemical solution storage unit 6 to flow through the flow path unit 7 when the piston 21 slides in the internal space 22A of the cylinder unit 22 (FIG. 4).
  • the drive unit 9 drives the piston 21 based on the control of the CPU 101 (FIG. 18), and slides the piston 21 in the internal space 22 ⁇ / b> A of the cylinder unit 22.
  • the substrate unit 10 is provided with a power source unit 104 (FIG. 18) for supplying power and a circuit such as a CPU 101.
  • medical solution storage part 6 inserts piston 12 from the open end side to the outer cylinder 11 formed in a cylindrical shape, as shown in FIG.
  • the chemical liquid storage unit 6 stores the chemical liquid in a chemical liquid storage space 13 formed by the outer cylinder 11 and the piston 12.
  • the outer cylinder 11 is provided with a distal end portion 11B that closes the distal end of the cylindrical main body portion 11A, and the main body portion 11A and the distal end portion 11B are integrally formed.
  • the tip portion 11B is a surface (hereinafter referred to as an inscribed surface) that is in contact with the medicinal solution storage space 13 along a direction orthogonal to a direction along the axis of the main body portion 11A (hereinafter also referred to as a cylinder axis direction).
  • a hollow protrusion 11D having an opening penetrating to the outside is provided at the center of 11C.
  • the distal end portion 11B communicates with the protruding portion 11D, and an external port 11E protrudes in a direction opposite to the protruding portion 11D.
  • the suction pipe 7A is connected to the external port 11E.
  • the main body 11 ⁇ / b> A is provided with a regulating portion 11 ⁇ / b> F in which a portion longer than the length of the protruding portion 11 ⁇ / b> D protrudes inward from the inscribed surface 11 ⁇ / b> C on the inner peripheral surface in contact with the chemical solution storage space 13. That is, the main body portion 11A is formed such that the inner diameter of the restricting portion 11F is shorter than the inner diameter of the main body portion 11A other than the restricting portion 11F.
  • the piston 12 is inserted into the outer cylinder 11 from the end opposite to the distal end portion 11B, contacts the inner surface of the main body portion 11A along the circumferential direction, and is liquid-tight along the cylindrical axis direction of the main body portion 11A. It is slidably arranged.
  • the piston 12 is formed with a diameter larger than the inner diameter of the restricting portion 11F.
  • the medicinal solution storage unit 6 is configured such that the medicinal solution stored in the vial from a predetermined injection port (not shown) enters the medicinal solution storage space 13 in a state where the piston 12 is positioned closest to the tip end part 11B and is in contact with the regulating unit 11F. Injected.
  • the chemical solution storage unit 6 When the chemical solution is delivered into the body by the delivery unit 8, the chemical solution storage unit 6 sucks in through the protrusion 11 ⁇ / b> D and the external port 11 ⁇ / b> E while the piston 12 moves to the tip portion 11 ⁇ / b> B side by the chemical solution suction pressure by the delivery unit 8.
  • the chemical solution is sent to the tube 7A.
  • medical solution storage part 6 sends out a chemical
  • the chemical solution storage unit 6 when the piston 12 moves and the chemical solution is delivered, the bubbles attached to the side surface of the main body portion 11A move while being pushed by the piston 12, and the piston 12 comes into contact with the regulating portion 11F. At this time, since the air bubbles are accumulated in the space provided between the piston 12 and the inscribed surface 11C, it is possible to prevent the air bubbles from being sent to the outside. Further, since the chemical liquid storage unit 6 is provided with the protruding portion 11D protruding from the inscribed surface 11C on the chemical liquid storage space 13 side, bubbles attached to the side surface of the main body 11A when the chemical liquid is delivered. Can be prevented from being sent to the outside through the opening of the protrusion 11D. [3.
  • the delivery unit 8 includes a piston 21, a cylinder unit 22, lids 23 and 24, one-way valves 25 and 26, an X ring 27, an X ring fixing unit 28, and a fixing member 29. It is supposed to be configured.
  • the piston 21 has a diameter of, for example, 1.03 mm, and is slid with a predetermined stroke in an internal space 22 ⁇ / b> A formed in a hollow cylindrical shape formed in the cylinder portion 22 by being driven by the drive portion 9.
  • the material of the piston 21 include stainless steel, copper alloy, aluminum alloy, titanium material, thermoplastic elastomer such as polypropylene and polycarbonate, and the like.
  • the cylinder portion 22 is provided with an internal space 22A in which the piston 21 is inserted from one end and slides.
  • the cylinder portion 22 is provided such that a flow path 22B that is in contact with the other end of the internal space 22A and orthogonal to the internal space 22A penetrates between opposing side surfaces of the cylinder portion 22.
  • the cylinder part 22 is provided with an X ring 27 for preventing leakage of a chemical solution between the piston 21 and an X ring fixing part 28 for fixing the X ring 27 at one end where the piston 21 is inserted in the internal space 22A.
  • the X ring 27 is inserted into the cylinder portion 22 from the side of the cylinder portion 22 where the internal space 22A is provided, and is pressed and fixed by the X ring fixing portion 28.
  • a part of the X ring fixing part 28 is fitted into the cylinder part 22 and the X ring 27 is fixed so that the remaining part is exposed to the outside.
  • the flow path 22B is formed in a rectangular cross section whose horizontal width is the same as the diameter of the internal space 22A and whose height is shorter than the horizontal width.
  • Hydrophilic processing is performed on the surfaces of the internal space 22A and the flow path 22B.
  • the hydrophilic processing for example, plasma treatment or application of a surfactant (sodium stearate) or the like is applied. Note that hydrophilic processing may also be performed on the tip surface (upper surface) of the piston 21.
  • the diameter of the internal space 22A and the horizontal width of the flow path 22B are formed to have the same length, and the center position of the axis of the internal space 22A and the central position of the horizontal width of the flow path 22B are formed to coincide.
  • the cylinder portion 22 has lid portions 23 and 24 connected to the side surface on which the flow path 22B is formed via a fixing member 29, respectively.
  • the lid portions 23 and 24 are provided with flow passages 23A and 24A penetrating along the flow passage 22B at positions facing the flow passage 22B of the cylinder portion 22.
  • One end of the flow path 23A is connected to the flow path 22B of the cylinder part 22, and the other end of the flow path 23A is connected to the suction pipe 7A to connect the suction pipe 7A and the flow path 22B.
  • one end of the flow path 24A is connected to the flow path 22B of the cylinder part 22, and the other end of the flow path 24A is connected to the delivery pipe 7B, thereby communicating the flow path 22B and the delivery pipe 7B.
  • the delivery section 8 is provided with a one-way valve 25 between the flow path 23A of the lid section 23 and the flow path 22B of the cylinder section 22, and between the flow path 22B of the cylinder section 22 and the flow path 24A of the lid section 24. Is provided with a one-way valve 26.
  • the one-way valve 25 allows the chemical liquid flowing from the flow path 23A of the lid portion 23 to the flow path 22B of the cylinder portion 22 to pass, and does not allow the chemical liquid to pass from the flow path 22B of the cylinder portion 22 to the flow path 23A of the lid portion 23.
  • an umbrella valve is applied.
  • the one-way valve 26 allows the chemical liquid that flows from the flow path 22B of the cylinder portion 22 to the flow path 24AB of the lid portion 24 to pass, and does not allow the chemical liquid to pass from the flow path 22B of the cylinder portion 22 to the flow path 24A of the lid portion 24.
  • an umbrella valve is applied.
  • the delivery unit 8 is a position where the piston 21 is most retracted (hereinafter also referred to as a push-off position) when delivering a chemical solution from the chemical solution storage unit 6 into the living body (hereinafter also referred to as a withdrawal position).
  • the chemical solution that has been moved by the drive unit 9 in the internal space 22A and stored in the chemical solution storage unit 6 is sucked into the internal space 22A.
  • the delivery part 8 sends out the chemical
  • the delivery unit 8 can administer about 1 to 2 ⁇ L of a chemical solution into the user's body by reciprocating the piston 21 once.
  • the pressing position is set to a position where the tip of the piston 21 is on the same plane as the bottom surface of the flow path 22B (the surface to which the internal space 22A is connected) or a position within the flow path 22B. That is, as shown in FIG. 5, when the drive unit 9 moves the piston 21 to the pressing position, the position where the tip of the piston 21 is on the same plane as the bottom surface of the flow path 22B or within the flow path 22B from the position. Move to the position.
  • the delivery unit 8 causes the air bubbles present in the internal space 22A to move into the flow path 22B at the tip surface (upper surface) of the piston 21 when the piston 21 moves to the push-off position. Since it can push out, when the piston 21 is moved to the retracted position thereafter, the possibility that the bubbles are pulled back into the internal space 22A can be greatly reduced.
  • bubbles adhere to the side surface of the cylinder part that contacts the internal space or the tip surface of the piston, and the air bubbles present in the internal space cause the piston to slide. In some cases, it may not be pushed into the flow path.
  • the bubble repeatedly expands and contracts due to a change in the internal pressure that changes according to the movement of the piston, thereby changing the amount of the drug solution sucked into the internal space, and sending the set drug solution amount into the living body. Can not do. Therefore, with such a device, there is a possibility that the drug solution cannot be administered with high accuracy.
  • the drug solution administration device 1 pushes out the air bubbles existing in the internal space 22A into the flow path 22B when the piston 21 moves to the push-off position in the delivery unit 8, the piston 21 moves to the retract position thereafter. In doing so, only the chemical solution can be sucked into the internal space 22A. Thus, the drug solution administration device 1 can accurately administer the drug solution.
  • the drive unit 9 includes a base unit 31, a motor 32, a motor support unit 34, a motor fixing plate 35, a fixed plate support unit 36, a bearing unit 37, a coupling 38, and a bearing support unit 39. It is said. Each part of the drive unit 9 is arranged on the base unit 31.
  • the motor 32 is sandwiched between a motor support portion 34 and a motor fixing plate 35 supported by the fixing plate support portion 36 and fixed to the base portion 31.
  • the motor 32 is provided with a motor shaft 33 that protrudes from the side surface on the motor fixing plate 35 side.
  • a screw groove 33 ⁇ / b> A is formed on the side surface of the motor shaft 33.
  • the bearing portion 37 has a substantially rectangular parallelepiped shape that is elongated along the axial direction of the motor 32 and has a hollow interior.
  • the bearing portion 37 is provided with a screw hole 37A at the center of the side surface corresponding to the short side of the substantially rectangular parallelepiped shape, through which the motor shaft 33 of the motor 32 is inserted and screwed into the screw groove 33A.
  • the piston 21 is coaxially connected to the motor shaft 33 via a coupling 38 on a side surface facing a side surface provided with a screw hole 37 ⁇ / b> A corresponding to a short side of a substantially rectangular parallelepiped shape.
  • the bearing portion 37 is supported by the bearing support portion 39.
  • As the coupling 38 for example, a coupling that absorbs axial displacement between the motor shaft 33 and the piston 21 is applied.
  • the drive unit 9 rotates the motor shaft 33 when the motor 32 is driven, and the bearing unit 37 screwed to the motor shaft 33 in the axial direction is driven in accordance with the rotation. Move and reciprocate the piston 21 in the axial direction.
  • the drive unit 9 slides the piston 21 in the internal space 22 ⁇ / b> A of the cylinder unit 22. 6A and 6B, the piston 21 is in the retracted position, and in FIG. 7, the piston 21 is in the push-off position.
  • the drive unit 9 since the motor shaft 33 of the motor 32 is arranged coaxially with the piston 21, the drive unit 9 has a force applied to the bearing portion 37 by the rotation of the motor shaft 33 and the force applied to the piston 21. The applied force is in the same direction, and the thrust loss of the piston 21 is eliminated. Therefore, the drive unit 9 can slide the piston 21 with a stable stroke distance in the internal space 22 ⁇ / b> A of the cylinder unit 22.
  • the driving unit 9 can drive the piston 21 with a smaller force by eliminating the loss of thrust of the piston 21, the motor 32, the battery, and the like can be reduced, and the entire apparatus can be downsized. Can do.
  • the side surface of the piston 21 may be coated with diamond-like carbon to reduce sliding resistance.
  • the space between the X ring fixing portion 28 and the coupling 38 is covered with a tube-like flexible film 40.
  • the material of the film 40 for example, polyethylene or the like is applied.
  • the film 40 is fixed to the X ring fixing portion 28 and the coupling 38 without gaps in the circumferential direction by film fixing portions 41 and 42 having both ends made of, for example, O-rings. Since the film 40 has flexibility, the piston 21 is always in the range from the state where the piston 21 shown in FIG. 8A is in the retracted position to the state where the piston 21 shown in FIG. Can be kept covered.
  • the piston 21 can be slid within the internal space 22 ⁇ / b> A of the cylinder portion 22 without touching the air outside the film 40. Thereby, the chemical solution administration device 1 can further maintain the cleanliness of the piston 21 entering the internal space 22A.
  • the puncture mechanism 5 mainly includes a pushing portion 5A, a fixing plate portion 5B fixed to the inside of the front end side of the bottom surface 2A (FIG. 1) of the lower housing portion 2, and the fixing plate portion 5B.
  • the lid 5F is indicated by a dotted line.
  • the fixed plate portion 5 ⁇ / b> B has a substantially square plate shape, and a communication hole 51 that communicates with the puncture needle hole 2 ⁇ / b> B provided in the bottom surface 2 ⁇ / b> A of the lower housing portion 2 is provided at the center thereof. Yes. Further, plate-like projections 52A and 52B are provided on the left and right sides of the communication hole 51 at a predetermined interval.
  • the fixing plate 5B may be provided separately from the lower casing 2 of the drug solution administration device 1 and fixed to the lower casing 2 or the lower casing 2 And may be provided integrally. As shown in FIGS.
  • the base 5C has a substantially U-shaped cross section having three walls 53A, 53B, and 53C on the left and right and rear sides, and the left wall 53A and the right wall 53B.
  • fitting grooves 54A and 54B into which the protrusions 52A and 52B of the fixing plate portion 5B are fitted are provided at the center lower part thereof.
  • the base 5C is fixed at a predetermined position of the fixed plate portion 5B by fitting the projections 52A and 52B of the fixed plate portion 5B into these two fitting grooves 54A and 54B.
  • the fitting parts 54F and 54B are fitted above the center of the fitting grooves 54A and 54B, that is, in the center upper part, respectively.
  • Grooves 54C and 54D are provided.
  • the lower fitting grooves 54A and 54B are referred to as lower fitting grooves 54A and 54B
  • the upper fitting grooves 54C and 54D are referred to as upper fitting grooves 54C and 54D.
  • a groove 55A and a groove 55B (FIG. 10) extending from the lower end to the upper end are provided on the inner side surfaces of the left wall portion 53A and the right wall portion 53B at positions close to the rear end.
  • grooves 55A and 55B are grooves that serve as guides when the central portion 5D slides along the inner wall of the base 5C.
  • these grooves 55A and 55B are referred to as guide grooves 55A and 55B.
  • recessed portions 56A and 56B that are recessed outward are provided at the upper ends in front of the guide grooves 55A and 55B on the inner side surfaces of the left side wall portion 53A and the right side wall portion 53B, and the recessed portions 56C and 56D are provided at the lower ends. Is provided.
  • the recesses 56A and 56B located at the upper end are called upper recesses 56A and 56B
  • the recesses 56C and 56D located at the lower end are called lower recesses 56C and 56D.
  • the base 5C has no front side wall portion, the front end portions of the left side wall portion 53A and the right side wall portion 53B are bent inward at a right angle so that the central portion 5D is separated from the base 5C. It is designed to prevent it from coming off. Further, a U-shaped notch 57 into which the inner needle guide portion 5E is fitted is provided at the center of the upper end of the rear side wall portion 53C. Further, on the inner side surface of the rear side wall portion 53C, a spring fixing portion 58 (FIG. 11) for fixing one end of a coil spring (described later) is projected at the lower end of the left side position.
  • a spring folding portion 59 is provided so as to extend from the center of the lower end to a position immediately below the notch 57 (position near the center upper end).
  • the spring folding portion 59 is for folding back the other end of a coil spring (not shown) whose one end is fixed to the spring fixing portion 58.
  • the coil spring will be described in detail later, only the outer needle is pulled back into the drug solution administration device 1 after puncturing a puncture needle composed of a metal outer needle and a resin inner needle into the body of the user. belongs to. As shown in FIG.
  • the center portion 5D is fixed to the lower end of the shaft 60 of the pushing portion 5A, and the inside of the base 5C is vertically moved along the guide grooves 55A and 55B by pushing the pushing portion 5A. It can slide.
  • the pushing portion 5A is provided with a button 61 on the upper end of the shaft 60 in a shape that is easy to push with a finger (for example, a substantially disc shape having the same size as the belly of the finger).
  • a part of the central portion 5D is an outer needle 62 of a puncture needle. As shown in FIGS.
  • the inner needle guide portion 5 ⁇ / b> E includes a substantially columnar guide portion 63 that extends in the front-rear direction, and a plate that protrudes slightly forward from the center of the lower surface of the guide portion 63. It is comprised with the support part 64 of a shape.
  • the guide part 63 is provided with a passage 65 extending in the front-rear direction.
  • the guide portion 63 has a shape in which the front end portion of the lower surface is bent downward, and a downward opening 66 connected to the passage 65 is provided in front of the bent portion.
  • the guide part 63 is provided with a rearward opening 67 connected to the passage 65 on the rear surface.
  • the front opening 66 is referred to as a front opening 66
  • the rear opening 67 is referred to as a rear opening 67.
  • the inner needle guide portion 5E is fitted to the notch 57 of the base 5C with the front end portion of the guide portion 63 protruding forward from the rear side wall portion 53C of the base 5C. Attached to. At this time, the support portion 64 of the inner needle guide portion 5E comes into contact with the outer surface of the rear side wall portion 53C of the base 5C, thereby supporting the guide portion 63 so as to be orthogonal to the rear side wall portion 53C. To do.
  • the passage 65 of the inner needle guide portion 5E has a linear shape in a portion from the rear opening 67 to the vicinity of the front end, and a curved portion in which a portion from the front opening 66 ahead to the front opening 66 is curved and curved downward. Yes.
  • the passage 65 includes a front passage 68 which is a front portion from the center and a rear passage 69 which is a rear portion from the center.
  • the rear passage 69 is a single passage, whereas the front passage 68 is a front portion.
  • the passage 68 is divided into two upper and lower passages 68A and 68B.
  • the upper passage 68A of the front passage 68 is referred to as an upper passage 68A
  • the lower passage 68B is referred to as a lower passage 68B.
  • These upper and lower passages 68 ⁇ / b> A and 68 ⁇ / b> B have leading ends connected to the front opening 66 and rear ends connected to the rear passage 69.
  • the upper passage 68A is a passage through which the inner needle 50 passes and is thicker than the lower passage 68B.
  • the inner needle 50 passes through the rear passage 69 and the upper passage 68A, is bent downward at the front end of the upper passage 68A, extends downward from the front opening 66, and is inserted into the outer needle 62 in the center portion 5D. It has become. Further, in this passage 65, there is provided a slide portion 70 that can slide in the rear passage 69 and connects and fixes the rear end of the inner needle 50 and the front end of the delivery pipe 7B connected to the drug solution storage portion 6. It has been. Actually, when the slide portion 70 slides forward in the rear passage 69 of the inner needle guide portion 5E, the inner needle 50 moves forward in the passage 65 and is pushed downward from the front opening 66. It is like that.
  • the slide portion 70 when the front end of the slide portion 70 comes into contact with the rear end of the boundary portion 71 between the upper passage 68A and the lower passage 68B, the slide portion 70 cannot slide further forward. That is, the rear end of the boundary portion 71 functions as a stopper that restricts sliding of the slide portion 70, and this portion is hereinafter referred to as a slide stopper 71. Furthermore, the rear end of the belt portion 72 made of a metal or resin belt is fixed to the lower end of the slide portion 70. The belt portion 72 passes through the rear passage 69 and the lower passage 68B, is bent downward at the front end of the lower passage 68B and extends downward from the front opening 66, and the tip thereof is fixed to the center portion 5D. .
  • the center portion 5D and the slide portion 70 are connected by the belt portion 72, so that the slide portion 70 slides in conjunction with the slide of the center portion 5D.
  • the slide portion 70 is slid forward by the belt portion 72, and the inner needle 50 also moves.
  • the belt portion 72 and the slide portion 70 function as the inner needle pulling portion 73 that pulls the inner needle 50 along with the sliding of the central portion 5D by the pressing operation with respect to the pressing portion 5A.
  • the outer needle 62 which is a part of the center portion 5D and the inner needle 50 whose tip is inserted into the outer needle 62 move together.
  • the inner needle guide part 5E can remove a part of the side surface, and the inside can be easily confirmed by removing this part.
  • the inner needle 50 has a tubular shape in which a portion on the rear end side of a portion inserted into the outer needle 62 of the center portion 5D can be inserted into the upper passage 68A and has an inner diameter larger than the outer diameter of the inner needle 50. It is also inserted into the inner needle bending prevention portion 74.
  • the inner needle bending prevention portion 74 which will be described in detail later, is a resin member that prevents the inner needle 50 from bending between the center portion 5D and the front opening 66 of the inner needle guide portion 5E. It has become. As shown by a dotted line in FIG.
  • the lid 5F has a substantially rectangular plate shape covering the upper end of the base 5C, and a hole 75 through which the shaft 60 of the push-in part 5A passes is provided at a position near the center front end. Yes. Further, the lid portion 5F is provided with plate-like projections 76A and 76B projecting downward at the left and right ends, respectively. The lid portion 5F passes the shaft 60 of the push-in portion 5A through the hole 75, and the two left and right projections 76A and 76B are provided on the upper side of the left side wall portions 53A and 53B of the base 5C. By being fitted into the mating grooves 54C and 54D, it is fixed to the upper end of the base 5C.
  • the lid portion 5F may be provided separately from the upper housing portion 3 of the drug solution administration device 1 and fixed inside the front end side of the upper housing portion 3. It may be provided integrally with the body part 3.
  • the puncture mechanism 5 has such a configuration.
  • the central portion 5D will be described in more detail.
  • the center portion 5D is mainly fixed to the outer needle slide portion 80 having the outer needle 62 of the puncture needle, and the shaft 60 of the push portion 5A, and further, the push portion 5A and the outer needle slide portion 80 And a slide fixing / releasing portion 81 for fixing or releasing the fixing.
  • the outer needle slide portion 80 is stacked on the slide fixing / releasing portion 81.
  • the outer needle slide portion 80 has a substantially square U shape with the front side opened to the rear and the rear side opened rearward. Each part has a shape extending upward.
  • convex part 82A and 82B are formed in the right-and-left both side surface part of the rear side.
  • Each of the convex portions 82A and 82B is a portion fitted into the guide grooves 55A and 55B of the base 5C, whereby the outer needle slide portion 80 slides up and down along the guide grooves 55A and 55B of the base 5C. It can be done.
  • an arc-shaped recess 83 is provided at the center of the front end so as not to interfere with the shaft 60 of the pushing portion 5A.
  • the outer needle slide portion 80 is provided with a cylindrical projection 84 projecting downward at the center of the bottom surface, which is thicker than the outer needle 62 and has the same diameter as the communication hole 51 of the fixed plate portion 5B.
  • a metal outer needle 62 extends downward from the lower end of the protrusion 84.
  • the outer needle 62 is a hollow tubular needle having a length of 8 mm, an outer diameter of 0.4 mm, and an inner diameter of 0.2 mm.
  • the outer needle slide portion 80 is provided with a plate-like protrusion 85 having a lower protruding amount than the protrusion 84 on the right side of the protrusion 84.
  • the protrusion 84 at the center of the bottom surface is referred to as a center protrusion 84, and the protrusion 85 located on the right side of the center protrusion 84 is referred to as a right protrusion 85.
  • a recess 86 is provided at the center of the upper surface of the outer needle slide portion 80, and a communication hole 87 that reaches the lower end of the central projection 84 and communicates with the outer needle 62 is provided at the center of the recess 86.
  • the inner needle 50 extending downward from the front opening 66 of the inner needle guide portion 5E is inserted into the outer needle 62 through the communication hole 87. Further, the tip of the inner needle bending prevention portion 74 is attached to the recess 86. As a result, the inner needle 50 is inserted into the inner needle bending prevention portion 74 at a portion on the rear end side from the portion inserted into the outer needle 62.
  • the outer needle slide portion 80 configured as described above can slide in the vertical direction on the inner side of the base 5C between the inner needle guide portion 5E attached to the upper end of the base 5C and the fixed plate portion 5B. ing.
  • the outer needle slide portion 80 when the outer needle slide portion 80 is located at the uppermost position, the left and right side surfaces of the front end portion of the inner needle guide portion 5E are sandwiched between the left and right side surface portions on the rear side, and the front side of the inner needle guide portion 5E. A communication hole 87 is located immediately below the opening 66. At this time, the inner needle bending prevention portion 74 is almost entirely contained in the upper passage 68A of the inner needle guide portion 5E. Further, when the outer needle slide portion 80 is located at the lowermost position, the right projection 85 on the bottom surface abuts on the top surface of the fixed plate portion 5B, and the central projection 84 is formed in the communication hole 51 of the fixed plate portion 5B. Insert.
  • the central protrusion 84 does not protrude downward from the communication hole 51, and only the outer needle 62 protrudes from the communication hole 51.
  • the inner needle bending prevention portion 74 has a rear end portion left at the front end portion in the upper passage 68A of the inner needle guide portion 5E, and the remaining portion is exposed outside the upper passage 68A.
  • the slide fixing / releasing portion 81 is made of an elastic member, and includes a rectangular plate-shaped base 88 and U-shaped claw-shaped stoppers 89A and 89B formed at the front ends of both the left and right sides of the base 88.
  • the shaft 60 of the pushing portion 5 ⁇ / b> A is fixed to the center of the front end of the base portion 88.
  • the tip of the belt portion 72 of the inner needle pulling portion 73 described above is fixed to the rear end of the base portion 88.
  • the base 88 of the slide fixing / releasing part 81 is fixed to the pushing part 5A and the inner needle pulling part 73. That is, the pushing portion 5A and the inner needle pulling portion 73 are fixed through the slide fixing / releasing portion 81.
  • the base portion 88 is provided with a through-hole 90 penetrating in the vertical direction for passing the central protrusion 84 of the outer needle slide portion 80 and the outer needle 62 at a position near the rear end.
  • the left and right claw-shaped stoppers 89A and 89B are respectively composed of a lower claw portion 91, a center portion 92, and an upper claw portion 93, and the lower claw portion 91 extends from the side surface of the base portion 88 and the base portion 88. It is integrally molded.
  • the base 88, the claw-shaped stoppers 89A and 89B, and the shaft 60 of the pushing portion 5A may be integrally molded.
  • the left and right claw-shaped stoppers 89A and 89B are normally arranged such that the tip of the upper claw portion 93 is positioned outward from the tip of the lower claw portion 91. When added, the tip of each upper claw part 93 is deformed so as to approach each other.
  • the left and right claw-shaped stoppers 89A and 89B are elastic members, so that when the inner pressing force disappears, the upper claw portions 93 are deformed so as to move away from each other and return to their original shapes. Yes.
  • the left and right claw-shaped stoppers 89A and 89B are deformed in the direction in which the upper claw portion 93 is brought closer, the claw-shaped stoppers 89A and 89B are closed, and the claw-shaped stoppers 89A and 89B are deformed in the away direction. Let it open. When the claw-shaped stoppers 89A and 89B are closed, the upper claw portion 93 is positioned above the upper surface of the base portion 88 by a predetermined length.
  • the central protrusion 84 of the outer needle slide portion 80 is fitted into the communication hole 87 of the slide fixing / releasing portion 81 and the outer needle slide portion 80 is overlapped on the slide fixing / releasing portion 81.
  • the thickness of the slide fixing / releasing portion 81 is formed to be thinner than the protruding amount of the central protruding portion 84 of the outer needle slide portion 80, so that the tip of the central protruding portion 84 when overlapped is formed.
  • the part projects together with the outer needle 62 downward from the through hole 90 of the slide fixing / releasing part 81.
  • the tip end portion of the central projecting portion 84 projecting downward is a portion to be fitted into the communication hole 51 of the fixed plate portion 5B.
  • the left and right claw-shaped stoppers 89A and 89B are closed in the state where the outer needle slide part 80 is overlapped on the slide fixing / releasing part 81 as described above, the upper claw parts of the left and right claw-shaped stoppers 89A and 89B are closed.
  • the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81 by the outer needle slide portion 80 being sandwiched between 93 and the upper surface of the base 88. In this way, the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81.
  • the slide fixing / releasing portion 81 is also fixed to the pushing portion 5A, the fact that the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81 means that the slide fixing / releasing portion 81 is fixed. It means that 5 A of pushing parts and the outer needle slide part 80 are fixed via. Further, when the left and right claw-shaped stoppers 89A and 89B are opened from this state, the fixation between the slide fixing / releasing portion 81 and the outer needle slide portion 80 is released (that is, the pressing portion 5A and the outer needle slide portion 80 are fixed to each other). Is fixed).
  • the central portion 5D configured as described above is configured such that the outer needle slide portion 80 is overlaid on the slide fixing / releasing portion 81, and the inner needle 50 is inserted into the outer needle 62 of the outer needle slide portion 80, and the base 5C.
  • the guide grooves 55A and 55B are fitted inside the base 5C.
  • the center portion 5D is disposed at the inner upper end of the base 5C as an initial position.
  • a part of the puncture mechanism 5 (button 61, coil spring, etc.) is omitted.
  • the center portion 5D has the inner needle 50 bent downward by the inner needle guide portion 5E, with the communication hole 87 of the outer needle slide portion 80 positioned immediately below the front opening 66 of the inner needle guide portion 5E. Is inserted into the outer needle 62 through the communication hole 87.
  • the entire outer needle 62 is housed in the drug solution administration device 1, while the protruding amount of the push-in portion 5A from the drug solution administration device 1 is maximized.
  • the center portion 5D is located at the upper ends of the left side wall portion 53A and the right side wall portion 53B of the base 5C, and as shown in FIG. 15 (A), outside the left and right claw-shaped stoppers 89A and 89B.
  • the left and right claw-shaped stoppers 89A and 89B are open as shown in FIG. 14B.
  • a part of the puncture mechanism 5 (such as the pushing portion 5 ⁇ / b> A) is omitted and the shape of the outer needle slide portion 80 is deformed. That is, when the center portion 5D is at the initial position, the outer needle slide portion 80 is not yet fixed to the slide fixing / releasing portion 81. Further, when in this initial position, the outer needle slide portion 80 of the center portion 5D is positioned in front of the upper end of the spring folding portion 59 provided on the rear side wall portion 53C of the base 5C, as shown in FIG.
  • the coil spring 94 having one end fixed to the spring fixing portion 58 provided at the lower left end of the rear side wall portion 53C of the base 5C is bent downward by the spring folding portion 59 into a J-shape. In this state, the other end is fixed to a predetermined position on the right side of the rear portion of the outer needle slide portion 80. At this time, the coil spring 94 is in a natural length state that does not expand and contract. Then, from this state, it is assumed that the user pushes the pushing portion 5A into the drug solution administration device 1.
  • the left and right claw-shaped stoppers 89A and 89B of the slide fixing / releasing portion 81 are released from the upper concave portions 56A and 56B of the base 5C and are pressed inward by the left side wall portion 53A and the right side wall portion 53B.
  • the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81, and the center portion 5D slides downward inside the base 5C as shown in FIG. 15B in this state. Go.
  • the entire coil spring 94 is extended so as to be deformed from the J shape to the U shape. Yes. [6.
  • the puncture mechanism 5 When actually puncturing the outer needle 62 and the inner needle 50, which are puncture needles, into the user's body will be described in detail.
  • the puncture mechanism 5 has the center portion 5D set at the initial position, the entire outer needle 62 is accommodated in the drug solution administration device 1, and the pushing portion 5A.
  • the amount of protrusion from the liquid medicine administration device 1 is the maximum.
  • the center portion 5D has an upper recessed portion 56A provided at the upper ends of the left wall portion 53A and the right wall portion 53B on the outside of the left and right claw-shaped stoppers 89A and 89B.
  • the left and right claw-shaped stoppers 89A and 89B are open, and the outer needle slide part 80 is not fixed to the slide fixing / releasing part 81.
  • the inner needle 50 has its distal end kept substantially at the same position as the distal end of the outer needle 62 and does not protrude from the distal end of the outer needle 62. Is inserted inside.
  • the pusher 5A is pushed into the drug solution administration device 1.
  • the central portion 5D slides downward inside the base 5C.
  • the left and right claw-shaped stoppers 89A and 89B are removed from the upper concave portions 56A and 56B, so that there is no space to open to the outside, and the left and right claw-shaped stoppers 89A and 89B are closed by being pressed inward by the left wall portion 53A and the right wall portion 53B.
  • the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81, and the pushing portion 5A and the outer needle slide portion 80 are fixed. Thereafter, the outer needle slide portion 80 slides downward together with the slide fixing / releasing portion 81 as the push portion 5A is pushed.
  • the center portion 5D is provided at the initial position without fixing the outer needle slide portion 80 to the slide fixing / releasing portion 81, and when the pushing portion 5A is pushed in, first, the claw-like shape of the slide fixing / releasing portion 81 is provided.
  • the stoppers 89A and 89B are closed and the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81, and then the slide is moved downward with the outer needle slide portion 80 fixed to the slide fixing / releasing portion 81. It has become.
  • the central portion 5D slides downward together with the pushing portion 5A in this way, the belt portion 72 fixed to the slide fixing / releasing portion 81 of the central portion 5D is slid in the inner needle guide portion 5E.
  • the inner needle 50 is pulled by sliding the part 70 forward.
  • the inner needle 50 moves with the outer needle 62 reliably while maintaining the position where the tip of the inner needle 50 is substantially the same as the tip of the outer needle 62 and does not protrude from the tip of the outer needle 62.
  • the central portion 5D slides downward together with the pushing portion 5A in this way, the interval between the inner needle guide portion 5E and the central portion 5D is widened, and the inner needle 50 is exposed outside the inner needle guide portion 5E within this range. Will do.
  • the portion located between the inner needle guide portion 5E and the center portion 5D may be bent along with the slide of the center portion 5D if there is nothing to guide. .
  • this portion is protected by being inserted into the inner needle bending prevention portion 74.
  • the inner needle bending prevention portion 74 is configured to guide a portion of the entire inner needle 50 located between the inner needle guide portion 5E and the central portion 5D. Is prevented from bending.
  • the coil spring 94 having the other end fixed to the outer needle slide portion 80 of the center portion 5D extends. To go.
  • the outer needle 62 of the center portion 5D slides downward while holding the inner needle 50 inside, and protrudes from the puncture needle hole 2B through the communication hole 51 of the fixed plate portion 5B.
  • the pushing portion 5A is pushed and the entire shaft 60 of the pushing portion 5A is housed in the drug solution administration device 1 as shown in FIGS. 15C and 17A, at this time, the pushing portion 5A is The portion protruding from the drug solution administration device 1 is only the button 61, and the amount of protrusion is minimized.
  • the pushing portion 5A is pushed to the end in this way, the central portion 5D reaches the lower end of the base 5C at this time.
  • the outer needle 62 and the inner needle 50 which are puncture needles, are punctured deeply into the user's body as shown in FIG. 19B.
  • the length of the part punctured in a user's body is designed so that it may be 7 mm, for example.
  • the lower concave portions 56C and 56D provided at the lower ends of the left side wall portions 53A and 53B are positioned outside the claw-shaped stoppers 89A and 89B of the central portion 5D, so that the claw-shaped stoppers 89A and 89B are As shown in FIG. 17B, the force that is pressed inwardly disappears and opens. As a result, the fixation between the slide fixing / releasing part 81 and the outer needle sliding part 80 at the center part 5D is released, and the fixing between the pushing part 5A and the outer needle sliding part 80 is released.
  • this portion is prevented from bending as the outer needle slide portion 80 slides. Further, as described above, the inner needle 50 is prevented from being bent between the inner needle guide portion 5E and the outer needle slide portion 80, so that the inner needle 50 comes off from the user's body or is used. It is also possible to prevent the portion placed in the body of the person from becoming shorter. That is, it can be said that the inner needle 50 can be punctured into the user's body more reliably. In this manner, the puncture mechanism 5 punctures the inner needle 50 together with the outer needle 62 in the user's body in accordance with the pushing operation of the pushing portion 5A, and the pushing portion 5A is moved until the center portion 5D reaches the lower end of the base 5C.
  • the button 61 of the pushing portion 5A serves as a lid of the upper housing portion 3, and packing around the shaft 60 of the pushing portion 5A (not shown). Is provided with a waterproof structure that prevents water from entering the interior.
  • the medicinal solution administration device 1 slides the center portion 5D having the outer needle 62 downward and is fixed to the pushing portion 5A via the center portion 5D.
  • the inner needle pulling portion 73 thus pulled pulls the inner needle 50
  • the outer needle 62 and the inner needle 50 inserted into the outer needle 62 are caused to protrude from the drug solution administration device 1, so that the user's body. Puncture into.
  • the medicinal solution administration device 1 opens the claw-shaped stoppers 89A and 89B of the center portion 5D, and only the outer needle slide portion 80 of the center portion 5D is restored by the restoring force of the coil spring 94.
  • the outer needle 62 is pulled back into the drug solution administration device 1 while the inner needle 50 is left in the body of the user.
  • the medicinal solution administration device 1 administers the medicinal solution stored in the medicinal solution storage unit 6 into the body of the user through the inner needle 50 by the delivery unit 8.
  • the drug solution administration device 1 uses the double needle puncture needle 50 as an indwelling needle, so that the diameter of the indwelling needle is smaller than that of a conventional puncture needle using the outer needle 62 as an indwelling needle. Can be easily reduced. That is, the medicinal solution administration device 1 can narrow the inner needle 50 as an indwelling needle, which is a portion to be placed in the user's body, thereby reducing the burden on the user.
  • the inner needle 50 made of a resin material can be manufactured with a thin tube, and its inner diameter can be made larger than that of a metal needle having the same outer diameter.
  • the medicinal solution administration device 1 can perform from the puncture of the puncture needle (the outer needle 62 and the inner needle 50) to the withdrawal of the outer needle 62 at a time only by pushing the pushing portion 5A.
  • a driving unit such as a motor is not required, the configuration can be simplified, and the size can be easily reduced.
  • the medicinal solution administration device 1 mainly includes functions necessary for the puncture mechanism 5 including the pushing portion 5A, the outer needle slide portion 80, the slide fixing / releasing portion 81, the inner needle pulling portion 73, and the coil spring 94 ( By realizing the puncture of the puncture needle and the return of the outer needle 62), the function required for the puncture mechanism 5 can be realized while suppressing the number of parts. Further, when the puncture is performed, the medicinal solution administration device 1 causes the inner needle to be pulled by the inner needle pulling portion 73 fixed to the pushing portion 5A via the outer needle sliding portion 80 as the outer needle sliding portion 80 slides by pushing the pushing portion 5A. By pulling 50, the inner needle 50 can be reliably moved together with the outer needle 62.
  • the chemical solution administration apparatus 1 includes a CPU (Central Processing Unit) 101, a ROM (Read Only Memory) 102, a RAM (Random Access Memory) 103, a power supply unit 104, an interface unit (I / F unit) 105.
  • a CPU Central Processing Unit
  • ROM Read Only Memory
  • RAM Random Access Memory
  • I / F unit interface unit
  • the notification unit 106 and the drive unit 9 are connected via a bus 107.
  • the CPU 101, ROM 102, RAM 103, power supply unit 104 and notification unit 106 are arranged on the substrate unit 10.
  • a battery is applied to the power supply unit 104.
  • the notification unit 106 is a speaker.
  • the interface unit 105 is arranged on the upper casing unit 3 or the lower casing unit 2 and is adapted with a button (not shown) for receiving a user input command.
  • the CPU 101 performs overall control by reading the basic program stored in the ROM 102 into the RAM 103 and executing it, and executes various processes by reading out and executing various application programs stored in the ROM 102 into the RAM 103.
  • the CPU 101 When the CPU 101 administers the medicinal solution to the user, it reads out the medicinal solution administration program to the RAM 103 and executes the medicinal solution administration process. In addition, after the puncture needle is punctured into the user's skin by the puncture mechanism 5, parameters such as a dose and a dose rate input via the interface unit 105 are set. Then, the CPU 101 controls the drive unit 9 based on the set parameters and starts administration of the drug solution. [8. Other Embodiments] [8-1. Other Embodiment 1] In the above-described embodiment, the case where the present invention is applied to the drug solution administration device 1 that administers a drug solution into the user's body has been described.
  • FIG. 21 shows the sensor device 200.
  • This sensor device 200 has the same puncture mechanism 5 as the drug solution administration device 1, but does not have the drug solution storage unit 6, the delivery unit 8, and the drive unit 9, and instead acquires biological information from the sensor. It has a control unit 201 and a transmission unit 202 that wirelessly transmits this biological information to the outside. As shown in FIG.
  • a sensor 203 is attached to the tip of the inner needle 50 of the sensor device 200, and the sensor 203 and the control unit 201 are electrically connected to the inner needle 50.
  • a signal line 204 is inserted.
  • the puncture mechanism 5 punctures the user's body with the outer needle 62 into which the inner needle 50 having the sensor 203 attached at the tip is inserted.
  • the sensor device 200 pulls only the outer needle 62 back into the sensor device 200 while the sensor 203 is left in the user's body.
  • the control unit 201 of the sensor device 200 acquires biological information obtained from the sensor 203 and wirelessly transmits the information to the outside via the transmission unit 202. [8-2.
  • the puncture mechanism (outer needle 62 and inner needle 50) is punctured into the user's body by the puncture mechanism 5 shown in FIGS. 9 to 13, and only the outer needle 62 is pulled back.
  • the puncture needle may be punctured and the outer needle pulled back by a puncture mechanism other than the puncture mechanism 5 shown in FIGS. [8-3.
  • Other Embodiment 3 In the above-described embodiment, after the puncture needle composed of the metal outer needle 62 and the resin inner needle 50 is punctured into the body of the user, only the outer needle 62 is pulled back into the drug solution administration device 1.
  • the coil spring 94 is used as the elastic member.
  • the present invention is not limited to this, and an elastic member other than the coil spring 94 may be used as long as the elastic member functions in the same manner as the coil spring 94.
  • the puncture mechanism 5 is provided with the inner needle bending prevention portion 74 that covers the inner needle 50 between the central portion 5D and the front opening 66 of the inner needle guide portion 5E.
  • the puncture mechanism 5 may have a configuration in which the inner needle bending prevention portion 74 is omitted.
  • the inner needle pulling portion 73 of the puncture mechanism 5 is configured by the belt-like belt portion 72 and the slide portion 70.
  • the inner needle pulling portion 73 may be configured by a wire portion made of a metal or resin wire and the slide portion 70.
  • the front end of the wire portion may be fixed to the slide fixing / releasing portion 81 and the rear end may be fixed to the slide portion 70.
  • the present invention is not limited to this, and it can be bent freely like a belt or a wire, does not expand and contract, and the slide fixing / releasing part 81 and the slide part 70 can be connected so that their distance is always constant. Any member other than a belt or wire may be used.
  • the present invention can be applied to the medical field, for example.
  • SYMBOLS 1 Chemical solution administration apparatus, 2 ... Lower housing

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

An objective of the present invention is to propose a puncture device and a medical fluid application device whereby it is possible, with a simple configuration, to reliably puncture with a dual structure puncture needle wherein an inner needle is an indwelling needle. When a push part (5A) is pushed, a central part (5D) having an outer needle (62) slides downward, and an inner needle pulling part (72) which is anchored to the push part (5A) pulls an inner needle (50), thereby puncturing the interior of a user's body with the outer needle (62) and the inner needle (50) which is inserted within the outer needle (62). When the push part (5A) is pushed to the utmost, hook-shaped stoppers (89A, 89B) of the central part (5D) are opened, returning only an outer needle slide part (80) of the central part (5D) to the original location by the restoring force of a coil spring (94), thereby retracting only the outer needle (62) within a medical fluid application device (1) while leaving the inner needle (50) within the body. Thus, it is possible to simplify the configuration, and to reliably puncture the interior of the user's body with the inner needle (50) together with the outer needle (62), without requiring a separate drive part, as an example.

Description

穿刺装置及び薬液投与装置Puncture device and drug solution administration device
 本発明は、穿刺装置及び薬液投与装置に関し、例えばインスリンを体内に投与する場合に適用して好適なものである。 The present invention relates to a puncture device and a drug solution administration device, and is suitable for application when, for example, insulin is administered into the body.
 従来、薬液(インスリン)を投与する装置として、使用者の皮膚に付着させて用いられる携帯型の装置であって、外筒内に充填された薬液をプランジャーを介して押し出すことにより体内に投与する、所謂シリンジポンプ型の薬液投与装置が提案されている(例えば、特許文献1参照)。
 また薬液投与装置では、使用者の体内に穿刺した穿刺針を介して薬液を投与するようになっており、この穿刺針の構造として、従来、金属製の内針とプラスチック製の外針とでなる二重構造の穿刺針が提案されている(例えば特許文献2参照)。
 この二重構造でなる穿刺針は、金属製の内針をプラスチック製の外針の先端から突出させた状態で使用者の体内に穿刺された後、金属製の内針がプラスチック製の外針から抜き取られ、外針のみを使用者の体内に留置させた状態で、この外針を介して薬液を投与するようになっている。
2. Description of the Related Art Conventionally, as a device that administers medicinal solution (insulin), it is a portable device that is used by adhering to the user's skin and is administered into the body by pushing out the medicinal solution filled in the outer cylinder through a plunger. A so-called syringe pump type drug administration device has been proposed (see, for example, Patent Document 1).
In addition, in a chemical solution administration device, a chemical solution is administered through a puncture needle that is punctured into a user's body. Conventionally, as a structure of this puncture needle, a metal inner needle and a plastic outer needle are used. A double-structured puncture needle is proposed (see, for example, Patent Document 2).
This double puncture needle is inserted into the user's body with the metal inner needle protruding from the tip of the plastic outer needle, and then the metal inner needle is the plastic outer needle. The drug solution is administered through the outer needle in a state where only the outer needle is removed from the body and is left in the body of the user.
特表2010−501283号公報Special table 2010-501283 gazette 特開2002−58747号公報JP 2002-58747 A
 ところで、従来の二重構造の穿刺針では、外針を使用者の体内に留置する留置針として機能させるようになっている。
 この留置針の径を小さくすれば、使用者の痛みを軽減できるが、従来の穿刺針の場合、留置針としての外針の内側に金属製の内針を挿入する構造のため、留置針としての外針の内径を金属製の内針の外径より大きくしなければならず、留置針の径を小さくすることが難しかった。
 ここで、外針ではなく内針を留置針とする穿刺針を実現できれば、外針を留置針とする従来の穿刺針と比して、留置針の径を容易に小さくでき、使用者の負担を一段と軽減できるものと考えられる。
 しかしながら、このような穿刺針で穿刺を行う場合、内針を使用者の体内に留置させたまま外針のみを抜き取るための新たな穿刺機構が必要であり、この新たな穿刺機構についても、簡易な構成で確実に穿刺針を穿刺できるようにすることが要求される。
 本発明は以上の点を考慮してなされたもので、簡易な構成で、内針を留置針とする二重構造の穿刺針を確実に穿刺することのできる穿刺装置及び薬液投与装置を提案しようとするものである。
 かかる課題を解決するため本発明の穿刺装置においては、外針と当該外針内に挿入される内針との二重構造でなる穿刺針と、前記穿刺針を収納する筐体部と、前記筐体部内に設けられ、前記外針内に前記内針の先端部が挿入されている状態の前記穿刺針を前記筐体部から突出させて使用者の体内に穿刺した後、当該穿刺針の内針は体内に留置させたまま、当該穿刺針の外針のみを前記筐体部内に引き戻す穿刺機構とを有し、前記穿刺機構は、前記筐体部に対して押込可能な押込部と、前記筐体部内をスライド可能で、前記外針を有する外針スライド部と、前記押込部と前記外針スライド部とを固定又は固定を解除する固定解除部と、一端が前記筐体部に固定されると共に他端が前記外針スライド部に固定される弾性部材と、一端が前記押込部に固定されると共に他端が前記内針の後端部に固定され、前記押込部の押し込みにともなって前記内針を牽引する内針牽引部とを有し、前記押込部と前記外針スライド部とが前記固定解除部により固定された状態で前記押込部が押し込まれると、前記外針スライド部が一方向にスライドすると共に前記内針牽引部により前記内針が牽引されることで、前記外針が前記内針と共に前記筐体部から突出して使用者の体内に穿刺され、さらに前記外針スライド部が所定位置までスライドすると、前記固定解除部により前記押込部と前記外針スライド部との固定が解除され、前記弾性部材により前記外針スライド部のみが他方向にスライドして、前記内針を体内に留置させたまま、前記外針のみを前記筐体部内に引き戻すようにした。
 また本発明の薬液投与装置においては、外針と当該外針内に挿入される内針との二重構造でなる穿刺針と、前記穿刺針を収納する筐体部と、前記筐体部内に設けられ、前記外針内に前記内針の先端部が挿入されている状態の前記穿刺針を前記筐体部から突出させて使用者の体内に穿刺した後、当該穿刺針の内針は体内に留置させたまま、当該穿刺針の外針のみを前記筐体部内に引き戻す穿刺機構と、薬液を貯蔵する薬液貯蔵部と、前記薬液貯蔵部に貯蔵された薬液を体内に留置させた前記内針を介して体内に送出する送出部とを有し、前記穿刺機構は、前記筐体部に対して押込可能な押込部と、前記筐体部内をスライド可能で、前記外針を有する外針スライド部と、前記押込部と前記外針スライド部とを固定又は固定を解除する固定解除部と、一端が前記筐体部に固定されると共に他端が前記外針スライド部に固定される弾性部材と、一端が前記押込部に固定されると共に他端が前記内針の後端部に固定され、前記押込部の押し込みにともなって前記内針を牽引する内針牽引部とを有し、前記押込部と前記外針スライド部とが前記固定解除部により固定された状態で前記押込部が押し込まれると、前記外針スライド部が一方向にスライドすると共に前記内針牽引部により前記内針が牽引されることで、前記外針が前記内針と共に前記筐体部から突出して使用者の体内に穿刺され、さらに前記外針スライド部が所定位置までスライドすると、前記固定解除部により前記押込部と前記外針スライド部との固定が解除され、前記弾性部材により前記外針スライド部のみが他方向にスライドして、前記内針を体内に留置させたまま、前記外針のみを前記筐体部内に引き戻すようにした。
 このように、押込部に対する押し込み操作のみで、穿刺針の穿刺から外針の引き戻しまでを行うことのできる機構としたことで、例えば別途駆動部などを必要とせず、穿刺機構の構成を簡易化でき、そのうえで、押込部の押し込みにともなって外針スライド部がスライドすると共に内針牽引部が内針を牽引することで、外針と共に内針を使用者の体内に確実に穿刺することができる。
 本発明によれば、押込部に対する押し込み操作のみで、穿刺針の穿刺から外針の引き戻しまでを行うことのできる機構としたことで、例えば別途駆動部などを必要とせず、穿刺機構の構成を簡易化でき、そのうえで、押込部の押し込みにともなって外針スライド部がスライドすると共に内針牽引部が内針を牽引することで、外針と共に内針を使用者の体内に確実に穿刺することができ、かくして、簡易な構成で、内針を留置針とする二重構造の穿刺針を確実に穿刺することのできる穿刺装置及び薬液投与装置を実現できる。
By the way, in the conventional double-structured puncture needle, it is made to function as an indwelling needle which indwells an outer needle in a user's body.
If the diameter of the indwelling needle is reduced, the pain of the user can be reduced. However, in the case of a conventional puncture needle, a metal inner needle is inserted inside the outer needle as the indwelling needle. The inner diameter of the outer needle had to be larger than the outer diameter of the metal inner needle, and it was difficult to reduce the diameter of the indwelling needle.
Here, if a puncture needle having an indwelling needle as an indwelling needle instead of an outer needle can be realized, the diameter of the indwelling needle can be easily reduced as compared to a conventional puncture needle using the outer needle as an indwelling needle, and the burden on the user is reduced. It is thought that this can be further reduced.
However, when puncturing with such a puncture needle, a new puncture mechanism is required for extracting only the outer needle while the inner needle is left in the user's body, and this new puncture mechanism is also simplified. It is required to ensure that the puncture needle can be punctured with a simple configuration.
The present invention has been made in consideration of the above points, and proposes a puncture device and a drug solution administration device capable of reliably puncturing a double puncture needle having an inner needle as an indwelling needle with a simple configuration. It is what.
In order to solve such a problem, in the puncture device of the present invention, a puncture needle having a double structure of an outer needle and an inner needle inserted into the outer needle, a housing portion for storing the puncture needle, The puncture needle is provided in the housing part and the puncture needle in a state where the distal end portion of the inner needle is inserted into the outer needle is projected from the housing part and punctured into the body of the user. A puncture mechanism that pulls back only the outer needle of the puncture needle into the housing while the inner needle is left in the body, and the puncture mechanism includes a pusher that can be pushed into the housing; and An outer needle slide portion having the outer needle that can slide in the housing portion, a fixing release portion that fixes or releases the pushing portion and the outer needle slide portion, and one end fixed to the housing portion And an elastic member whose other end is fixed to the outer needle slide portion and one end of the pushing portion The other end is fixed to the rear end portion of the inner needle, and has an inner needle pulling portion that pulls the inner needle as the pressing portion is pushed, and the pushing portion and the outer needle sliding portion When the push-in portion is pushed in with the fixed release portion being fixed, the outer needle slide portion slides in one direction and the inner needle is pulled by the inner needle pulling portion. When the needle protrudes from the housing portion together with the inner needle and is punctured into the user's body, and the outer needle slide portion slides to a predetermined position, the fixing release portion causes the push portion and the outer needle slide portion to The fixation was released, and only the outer needle slide portion was slid in the other direction by the elastic member, and only the outer needle was pulled back into the housing portion while the inner needle was left in the body.
Further, in the drug solution administration device of the present invention, a puncture needle having a double structure of an outer needle and an inner needle inserted into the outer needle, a housing portion for storing the puncture needle, and a housing portion The puncture needle with the tip of the inner needle inserted into the outer needle is protruded from the housing and punctured into the body of the user, and the inner needle of the puncture needle A puncture mechanism for pulling back only the outer needle of the puncture needle into the housing part, a medicinal solution storage part for storing a medicinal solution, and the medicinal solution stored in the medicinal solution storage part in the body. And a puncture mechanism that can be pushed into the casing, and an outer needle that is slidable within the casing and has the outer needle. A fixing part for fixing or releasing the sliding part, and the pushing part and the outer needle sliding part; One end is fixed to the housing part and the other end is fixed to the outer needle slide part, and one end is fixed to the pushing part and the other end is fixed to the rear end part of the inner needle. An inner needle pulling portion that pulls the inner needle as the pushing portion is pushed, and the pushing portion is pushed in a state where the pushing portion and the outer needle slide portion are fixed by the fixing release portion. When the outer needle slide portion slides in one direction and the inner needle is pulled by the inner needle pulling portion, the outer needle protrudes from the housing portion together with the inner needle, and the user's body. When the outer needle slide portion is further slid to a predetermined position, the fixation release portion releases the fixation between the push-in portion and the outer needle slide portion, and the elastic member removes only the outer needle slide portion. Slide in direction Te, while the inner needle was indwelled in the body, and to retract only the outer needle in the housing portion.
As described above, the mechanism that can perform from the puncture of the puncture needle to the return of the outer needle can be performed only by pushing the push portion, and for example, the configuration of the puncture mechanism is simplified without the need for a separate drive portion or the like. In addition, the outer needle slide part slides as the pushing part is pushed, and the inner needle pulling part pulls the inner needle, so that the inner needle together with the outer needle can be reliably punctured into the user's body. .
According to the present invention, a mechanism that can perform from the puncture of the puncture needle to the retraction of the outer needle only by the pushing operation with respect to the push-in portion, for example, does not require a separate drive unit, and the configuration of the puncture mechanism In addition, the outer needle slide part slides as the push-in part is pushed in, and the inner needle pulling part pulls the inner needle, so that the inner needle together with the outer needle is securely punctured into the user's body. Thus, it is possible to realize a puncture device and a drug solution administration device that can reliably puncture a double puncture needle having an inner needle as an indwelling needle with a simple configuration.
 図1は、薬液投与装置の構成を示す略線図である。
 図2は、薬液投与装置の分解斜視図である。
 図3は、薬液貯蔵部の構成を示す略線図である。
 図4は、送出部の構成を示す略線図である。
 図5は、押切位置に移動されたピストンの様子を示す略線図である。
 図6は、駆動部の構成を示す略線図である。
 図7は、駆動部の構成を示す略線図である。
 図8は、フィルムを含む送出部及び駆動部の構成を示す略線図である。
 図9は、穿刺機構の構成を示す略線図である。
 図10は、穿刺機構の構成を示す略線図である。
 図11は、ベースの構成を示す略線図である。
 図12は、内針固定部の構成を示す略線図である。
 図13は、中心部の構成を示す略線図である。
 図14は、穿刺機構の動作の説明にともなう略線図である。
 図15は、コイルバネによる外針の引き戻しの説明にともなう略線図である。
 図16は、穿刺機構の動作の説明にともなう略線図である。
 図17は、穿刺機構の動作の説明にともなう略線図である。
 図18は、穿刺機構の動作の説明にともなう略線図である。
 図19は、穿刺針(外針+内針)の構成を示す略線図である。
 図20は、薬液投与装置の電気的構成を示す略線図である。
 図21は、他の実施の形態におけるセンサ装置の構成を示す略線図である。
 図22は、他の実施の形態における穿刺針の構成を示す略線図である。
FIG. 1 is a schematic diagram illustrating a configuration of a drug solution administration device.
FIG. 2 is an exploded perspective view of the chemical liquid administration device.
FIG. 3 is a schematic diagram illustrating a configuration of a chemical solution storage unit.
FIG. 4 is a schematic diagram illustrating the configuration of the sending unit.
FIG. 5 is a schematic diagram showing a state of the piston moved to the pressing position.
FIG. 6 is a schematic diagram illustrating the configuration of the drive unit.
FIG. 7 is a schematic diagram illustrating the configuration of the drive unit.
FIG. 8 is a schematic diagram illustrating a configuration of a delivery unit and a drive unit including a film.
FIG. 9 is a schematic diagram showing the configuration of the puncture mechanism.
FIG. 10 is a schematic diagram showing the configuration of the puncture mechanism.
FIG. 11 is a schematic diagram illustrating the configuration of the base.
FIG. 12 is a schematic diagram illustrating the configuration of the inner needle fixing portion.
FIG. 13 is a schematic diagram illustrating the configuration of the central portion.
FIG. 14 is a schematic diagram for explaining the operation of the puncture mechanism.
FIG. 15 is a schematic diagram for explaining the return of the outer needle by the coil spring.
FIG. 16 is a schematic diagram for explaining the operation of the puncture mechanism.
FIG. 17 is a schematic diagram for explaining the operation of the puncture mechanism.
FIG. 18 is a schematic diagram for explaining the operation of the puncture mechanism.
FIG. 19 is a schematic diagram showing a configuration of a puncture needle (outer needle + inner needle).
FIG. 20 is a schematic diagram illustrating an electrical configuration of the drug solution administration device.
FIG. 21 is a schematic diagram illustrating a configuration of a sensor device according to another embodiment.
FIG. 22 is a schematic diagram illustrating a configuration of a puncture needle according to another embodiment.
 以下に、図面について、本発明の一実施の形態を詳述する。
〔1.薬液投与装置の全体構成〕
 図1及び図2に示すように、薬液投与装置1は、使用者の皮膚に貼り付けることにより保持されて使用される携帯型の装置であり、上側が開口し内部に空間が設けられた下筐体部2と該下筐体部2の開口に嵌合する上筐体部3により扁平な略直方体形状に形成される。
 薬液投与装置1の大きさは、使用者の皮膚に貼り付けることができる程度にまで小型化されていればよいが、例えば横32mm、縦44mm、高さ11mm略直方体形状が挙げられる。
 下筐体部2には、両面テープ等でなる貼付部4が底面2Aに設けられる。薬液投与装置1は、貼付部4が使用者の皮膚に貼り付けられることにより該使用者に保持される。
 薬液投与装置1は、下筐体部2の底面2Aの前端に、内部に充填されたインスリンを使用者の体内へ投与するために該使用者の体内に穿刺される穿刺針(図示せず)を下筐体部2と上筐体部3とで形成される空間内から穿刺機構5により突出させるための穿刺針孔2Bが設けられる。尚、この穿刺針は、詳しくは後述するが、金属製の外針と、樹脂製の内針とでなる二重構造となっている。
 また薬液投与装置1は、上筐体部3の前端に、押込操作が可能な押込部5Aが設けられている。この押込部5Aは図2に示す穿刺機構5の一部であり、薬液投与装置1は、この押込部5Aが使用者に押し込まれることにより穿刺機構5が動作して、穿刺針孔2Bから穿刺針を突出させて穿刺針を使用者の体内に穿刺するようになっている。
 さらに薬液投与装置1は、下筐体部2と上筐体部3とで形成される空間に薬液貯蔵部6、流路部7、送出部8、駆動部9、基板部10等が設けられる。
 薬液貯蔵部6は、詳しくは後述するように、円筒形状をした外筒11内に、薬液が外部から充填される。
 流路部7は、吸込管7A、送出管7B、送出部8に形成される流路22B、23A、24A及び穿刺機構5の穿刺針の内針を含み、薬液貯蔵部6から体内までの薬液が流れる流路を形成する。吸込管7Aは、薬液貯蔵部6と送出部8に形成される流路23Aとを連通させる。送出管7Bは、送出部8に形成される流路24Aと穿刺機構5の穿刺針の内針とを連通させる。
 送出部8は、詳しくは後述するように、シリンダ部22(図4)の内部空間22A内をピストン21が摺動することにより、薬液貯蔵部6に貯蔵された薬液を流路部7を介して体内に送出する。
 駆動部9は、CPU101(図18)の制御に基づいてピストン21を駆動し、該ピストン21をシリンダ部22の内部空間22A内で摺動させる。
 基板部10は、電源電力を供給する電源部104(図18)やCPU101等の回路などが配される。
〔2.薬液貯蔵部の構成〕
 薬液貯蔵部6は、図3に示すように、円筒形状に形成される外筒11に、開口した端側からピストン12が挿入される。薬液貯蔵部6は、外筒11とピストン12とにより形成される薬液貯蔵空間13に薬液を貯蔵する。
 外筒11は、円筒形状の本体部11Aの先端に、該先端を塞ぐ先端部11Bが設けられ、本体部11Aと先端部11Bとが一体成形される。
 先端部11Bは、本体部11Aの軸に沿った方向(以下、これを筒軸方向とも呼ぶ)に対して直交する方向に沿って薬液貯蔵空間13側に接する面(以下、これを内接面とも呼ぶ)11Cの中央に、外部まで貫通された開口を有する中空の突出部11Dが突設される。
 また先端部11Bは、突出部11Dと連通して該突出部11Dとは反対の方向に外部ポート11Eが突設され、該外部ポート11Eに吸込管7Aが接続される。
 本体部11Aは、薬液貯蔵空間13と接する内周面における内接面11Cから突出部11Dの長さよりも長い部分が内側に突出した規制部11Fが設けられる。すなわち本体部11Aは、規制部11Fの内径が本体部11Aにおける規制部11F以外の部分の内径より短くなるように形成される。
 ピストン12は、先端部11Bとは反対側の末端から外筒11に挿入され、本体部11Aの内側面に周方向に沿って当接し、該本体部11Aの筒軸方向に沿って液密に摺動可能に配される。ピストン12は、直径が規制部11Fの内径よりも大きく形成される。
 薬液貯蔵部6は、ピストン12が最も先端部11B側に位置して規制部11Fに当接した状態で、所定の注入口(図示せず)からバイアルに貯蔵された薬液が薬液貯蔵空間13に注入される。このとき薬液貯蔵部6では、外筒11の内接面11Cとピストン12との間に規制部11Fにより若干の空間が開けられる。
 薬液貯蔵部6は、薬液が注入されるに連れてピストン12が末端側に移動され、所定量(例えば2ml)だけ薬液が注入される。このとき薬液貯蔵空間13には、予め存在していた気泡がそのまま残ることになる。
 薬液貯蔵部6は、送出部8により薬液が体内に送出される際、該送出部8による薬液吸引圧力によりピストン12が先端部11B側に移動しながら突出部11D及び外部ポート11Eを介して吸込管7Aに薬液を送出させる。そして薬液貯蔵部6は、ピストン12が突出部11Dに当接するまで薬液を送出させる。
 ところで薬液貯蔵部6では、薬液貯蔵空間13内に気泡が存在している場合、該気泡の殆どは壁面に付着される。従って薬液貯蔵部6では、ピストン12が移動して薬液が送出される際に、本体部11Aの側面に付着した気泡がピストン12により押されながら移動し、ピストン12が規制部11Fに当接した際に、該ピストン12と内接面11Cとの間に設けられた空間に気泡が溜まるので、外部に気泡が送出されることを防止できる。
 また薬液貯蔵部6は、突出部11Dが内接面11Cに対して薬液貯蔵空間13側に突設して設けられているので、薬液が送出される際に本体部11Aの側面に付着した気泡が突出部11Dの開口を通して外部に送出されることを防止できる。
〔3.送出部の構成〕
 送出部8は、図4(A)に示すように、ピストン21、シリンダ部22、蓋部23、24、一方向弁25、26、Xリング27、Xリング固定部28及び固定部材29を含む構成とされる。
 ピストン21は、例えば直径が1.03mmでなり、駆動部9により駆動されてシリンダ部22に形成された中空の円柱形状に形成された内部空間22A内で所定のストロークで摺動する。ピストン21の材質としては、例えば、ステンレス鋼、銅合金、アルミ合金、チタン材、ポリプロピレンやポリカーボネートなどの熱可塑性エラストマー等が挙げられる。
 シリンダ部22は、一端からピストン21が挿入されて摺動する内部空間22Aが設けられる。またシリンダ部22は、内部空間22Aの他端に接して該内部空間22Aと直交した流路22Bがシリンダ部22の対向する側面間を貫通するようにして設けられる。
 シリンダ部22は、内部空間22Aにおけるピストン21が挿入される一端に該ピストン21との間で薬液の漏洩を防止するXリング27及び該Xリング27を固定するXリング固定部28が設けられる。
 Xリング27は、シリンダ部22における内部空間22Aが設けられた面側からシリンダ部22内に挿入され、Xリング固定部28により押え付けられて固定される。Xリング固定部28は、一部がシリンダ部22内に嵌合され、残りの部分が外部に露出するようにしてXリング27を固定する。
 流路22Bは、図4(B)に示すように、横幅が内部空間22Aの径と同じ長さで、高さが横幅よりも短い長方形の断面に形成される。内部空間22A及び流路22Bの表面には親水性加工が施される。親水性加工として、例えばプラズマ処理や界面活性剤(ステアリン酸ナトリウム)の塗布等が適応される。なお、ピストン21の先端面(上面)にも親水性加工が施されていてもよい。
 シリンダ部22では、内部空間22Aの径と流路22Bの横幅が同一長さに形成され、内部空間22Aの軸の中心位置と流路22Bの横幅の中心位置が一致するように形成される。
 シリンダ部22は、流路22Bが形成された側面にそれぞれ蓋部23及び24が固定部材29を介して接続される。蓋部23及び24は、シリンダ部22の流路22Bと対向する位置に、該流路22Bに沿って貫通した流路23A及び24Aが設けられる。
 蓋部23は、流路23Aの一端がシリンダ部22の流路22Bに接続され、流路23Aの他端が吸込管7Aに接続され、吸込管7Aと流路22Bとを連通させる。
 蓋部24は、流路24Aの一端がシリンダ部22の流路22Bに接続され、流路24Aの他端が送出管7Bに接続され、流路22Bと送出管7Bとを連通させる。
 送出部8は、蓋部23の流路23Aとシリンダ部22の流路22Bとの間に一方向弁25が設けられ、シリンダ部22の流路22Bと蓋部24の流路24Aとの間に一方向弁26が設けられる。
 一方向弁25は、蓋部23の流路23Aからシリンダ部22の流路22Bへ流れる薬液を通過させ、シリンダ部22の流路22Bから蓋部23の流路23Aへは薬液を通過させないものであり、例えばアンブレラ弁が適応される。
 一方向弁26は、シリンダ部22の流路22Bから蓋部24の流路24ABへ流れる薬液を通過させ、シリンダ部22の流路22Bから蓋部24の流路24Aへは薬液を通過させないものであり、例えばアンブレラ弁が適応される。
 送出部8は、薬液貯蔵部6から生体内に薬液を送出する際、ピストン21が最も押し込まれる位置(以下、押切位置とも呼ぶ)から最も引き戻される位置(以下、これを引戻位置とも呼ぶ)まで内部空間22A内で駆動部9により移動され、薬液貯蔵部6に貯蔵された薬液を内部空間22A内に吸い出す。
 そして送出部8は、ピストン21が引戻位置から押切位置に駆動部9により移動されことにより、内部空間22Aに吸い出された薬液を生体内へ送出する。
 送出部8は、ピストン21を一往復させる動作で約1~2μLの薬液を使用者の体内に投与でき、この動作を設定された周期及び間隔で繰り返し行うことにより、所望の投与速度及び投与量で薬液を使用者に投与できる。
 ところで押切位置は、ピストン21の先端が流路22Bの底面(内部空間22Aが接続される面)と同一平面上となる位置又は該位置よりも流路22B内の位置に設定される。すなわち駆動部9は、図5に示すように、ピストン21を押切位置に移動させる際、該ピストン21の先端が流路22Bの底面と同一平面上となる位置又は該位置よりも流路22B内の位置まで移動させる。
 これにより送出部8は、内部空間22Aに気泡が存在した場合、ピストン21が押切位置に移動する際に内部空間22Aに存在する気泡を該ピストン21の先端面(上面)で流路22B内に押し出すことができるので、その後にピストン21が引戻位置に移動される際に気泡を再び内部空間22A内に引戻す可能性を大幅に減少させることができる。
 これに対してピストンの先端を流路内まで移動させない装置では、例えば内部空間に接するシリンダ部の側面やピストンの先端面に気泡が付着して内部空間内に存在する気泡がピストンの摺動の際に流路に押し出されないことが起こり得る。
 この場合、ピストンの移動に応じて変化する内部圧力の変化により気泡が膨張及び収縮を繰り返し、これにより、内部空間に吸い込まれる薬液量が変化してしまい、設定された薬液量を生体内に送出することができなくなる。従ってこのような装置では、精度よく薬液を投与できなくなる恐れがある。
 これに対して薬液投与装置1は、送出部8においてピストン21が押切位置に移動する際に内部空間22Aに存在する気泡を流路22B内に押し出すので、その後にピストン21が引戻位置に移動される際には内部空間22A内に薬液だけを吸い込むことができる。かくして薬液投与装置1は、精度よく薬液を投与することができる。
 また薬液投与装置1では、ピストン21の先端面、内部空間22A及び流路22Bの表面に親水性加工が施されているので、より内部空間22A及び流路22Bに気泡が残ってしまうことを防止することができる。
〔4.駆動部の構成〕
 駆動部9は、図6に示すように、土台部31、モータ32、モータ支持部34、モータ固定板35、固定板支持部36、軸受部37、カップリング38、軸受支持部39を含む構成とされる。
 駆動部9は、土台部31の上に各部が配される。モータ32は、モータ支持部34と固定板支持部36に支持されるモータ固定板35とにより挟持されて土台部31に固定される。
 モータ32は、モータ固定板35側の側面から突出するモータ軸33が設けられる。モータ軸33の側面にはネジ溝33Aが形成される。
 軸受部37は、モータ32の軸方向に沿って細長い略直方体状で内部が中空に形成される。軸受部37は、略直方体状の短辺に相当する側面中央に、モータ32のモータ軸33が貫通して配されてネジ溝33Aと螺合するネジ孔37Aが設けられる。
 軸受部37は、略直方体状の短辺に相当してネジ孔37Aが設けられた側面と対向する側面にカップリング38を介してピストン21がモータ軸33と同軸上に接続される。また、軸受部37は、軸受支持部39に支持される。なお、カップリング38は、例えば、モータ軸33とピストン21との軸方向のずれを緩衝するものが適応される。
 駆動部9は、図6及び図7に示すように、モータ32が駆動されることによりモータ軸33が回転し、該回転に応じてモータ軸33に螺合された軸受部37が軸方向に移動してピストン21を軸方向に往復動させる。これにより駆動部9は、ピストン21をシリンダ部22の内部空間22A内で摺動させる。なお図6(A)及び(B)においてはピストン21が引戻位置にあり、図7においてはピストン21が押切位置にある。
 このように駆動部9は、モータ32のモータ軸33がピストン21と同軸上に配されているので、モータ軸33が回転することにより軸受部37に加えられる力と、該力によりピストン21に加えられる力とが同一方向となり、ピストン21の推力の損失がなくなる。
 従って駆動部9は、ピストン21をシリンダ部22の内部空間22A内で安定したストローク距離で摺動させることができる。また駆動部9は、ピストン21の推力の損失がなくなることにより、より小さい力でピストン21を駆動することができるので、モータ32やバッテリ等を小さくすることができ、装置全体を小型化することができる。なお、ピストン21の側面には摺動抵抗を減らすためにダイヤモンドライクカーボンがコーティングされていてもよい。
 一方、ピストンとモータの軸部とが同軸上に配されていない装置では、軸部が回転することにより軸受部に加えられる力と、該力によりピストンに加えられる力とがオフセットすることにより、ピストンの推力の損失が増大すると共に、力のオフセットにより軸受部やピストンの摺動抵抗が増加することになり、ピストンのストロークが安定しないだけでなく、装置全体が大型化してしまう。
 ところで薬液投与装置1では、図8に示すように、Xリング固定部28とカップリング38との間がチューブ状の柔軟性を有するフィルム40で覆われる。フィルム40の材質としては、例えばポリエチレン等が適応される。
 フィルム40は、両端が例えばOリングでなるフィルム固定部41及び42によりXリング固定部28及びカップリング38に対してそれぞれ周方向にわたって隙間なく固定される。
 フィルム40は、柔軟性を有しているので、図8(A)に示すピストン21が引戻位置にある状態から、図8(B)に示すピストン21が押切位置にある状態にわたって常にピストン21を覆った状態を維持することができる。
 従って薬液投与装置1では、ピストン21をフィルム40外の空気に触れることなくシリンダ部22の内部空間22A内で摺動させることができる。これにより薬液投与装置1は、内部空間22A内に入り込むピストン21の清潔性をより保持することができる。
〔5.穿刺機構の構成〕
 次に、穿刺機構5の構成について詳しく説明する。穿刺機構5は、図9に示すように、主として、押込部5Aと、下筐体部2の底面2A(図1)の前端側内部に固定される固定板部5Bと、この固定板部5Bに突設されるベース5Cと、押込部5Aに対する押込操作に応じてベース5Cの内側を上下方向にスライド可能な中心部5Dと、ベース5Cの後方からベース5Cの内側へと内針50をガイドする内針ガイド部5Eと、ベース5Cの上端に取り付けられる蓋部5Fとを有している。尚、図9では、蓋部5Fを、点線で示している。
 図10に示すように、固定板部5Bは、略四角形の板状でなり、その中央に、下筐体部2の底面2Aに設けられる穿刺針孔2Bと連通する連通孔51が設けられている。
 さらにこの連通孔51の左右に所定の間隔を隔てて板状の突起部52A及び52Bが突設されている。
 尚、この固定板部5Bは、薬液投与装置1の下筐体部2とは別体に設けられて下筐体部2に固定されるようになっていてもよいし、下筐体部2と一体に設けられていてもよい。
 ベース5Cは、図10及び図11に示すように、左右と後側の3つの壁部53A、53B、53Cを有する断面略コの字型の形状でなり、左側壁部53A及び右側壁部53Bのそれぞれの外側面には、その中央下部に、固定板部5Bの突起部52A及び52Bのそれぞれが嵌合する嵌合溝54A及び54Bが設けられている。
 ベース5Cは、これら2つの嵌合溝54A及び54Bに、固定板部5Bの突起部52A及び52Bを嵌合させることで、固定板部5Bの所定位置に固定される。
 さらに左側壁部53A及び右側壁部53Bのそれぞれの外側面には、嵌合溝54A及び54Bの上方、すなわち中央上部に、蓋部5Fの突起部(後述する)のそれぞれが嵌合する嵌合溝54C及び54Dが設けられている。
 尚、ここでは、下側の嵌合溝54A及び54Bを下側嵌合溝54A及び54Bと呼び、上側の嵌合溝54C及び54Dを上側嵌合溝54C及び54Dと呼ぶことにする。
 さらに左側壁部53A及び右側壁部53Bのそれぞれの内側面には、後端寄りの位置に、下端から上端まで延在する溝55A及び溝55B(図10)が設けられている。
 これらの溝55A及び55Bは、中心部5Dがベース5Cの内壁に沿ってスライドするときのガイドとなる溝であり、以下、これらの溝55A及び55Bをガイド溝55A及び55Bと呼ぶこととする。
 さらに左側壁部53A及び右側壁部53Bのそれぞれの内側面には、ガイド溝55A及び55Bより前方の上端に、外側に凹んだ凹部56A及び56Bが設けられていると共に、下端に凹部56C及び56Dが設けられている。
 ここで、上端に位置する凹部56A及び56Bを上側凹部56A及び56Bと呼び、下端に位置する凹部56C及び56Dを下側凹部56C及び56Dと呼ぶ。これらの役割については、後述する。
 尚、ベース5Cは、前側壁部は存在しないものの、左側壁部53A及び右側壁部53Bの前端部が内側に直角に折れ曲げられた形状となっていることで、中心部5Dがベース5Cから外れてしまうことを防ぐようになっている。
 さらに後側壁部53Cの上端中央には、内針ガイド部5Eが嵌合するコの字型の切り欠き57が設けられている。
 さらに後側壁部53Cの内側面には、左寄りの位置の下端に、コイルバネ(後述する)の一端を固定するためのバネ固定部58(図11)が突設されている。
 さらに後側壁部53Cの内側面には、下端中央から切り欠き57のすぐ下の位置(中央上端寄りの位置)まで延在するバネ折返部59が突設されている。このバネ折返部59は、バネ固定部58に一端が固定されたコイルバネ(図示せず)の他端側を折り返すためのものである。尚、コイルバネについては、詳しくは後述するが、金属製の外針と樹脂製の内針とでなる穿刺針を使用者の体内に穿刺した後、外針のみを薬液投与装置1内に引き戻すためのものである。
 中心部5Dは、図10に示すように、押込部5Aの軸60の下端に固定されていて、押込部5Aに対する押し込み操作によりベース5Cの内側を、ガイド溝55A及び55Bに沿って上下方向にスライド可能となっている。
 またこの押込部5Aは、軸60の上端に、指で押し込み易い形状(例えば指の腹と同サイズの略円板状)のボタン61が設けられている。
 また、詳しくは後述するが、この中心部5Dの一部が穿刺針の外針62となっている。
 内針ガイド部5Eは、図10及び図12に示すように、前後方向に延材する略柱状のガイド部63と、このガイド部63下面の中央より若干前方寄りの位置に突設された板状の支持部64とで構成される。
 ガイド部63は、その内部に、前後方向に延在する通路65が設けられている。またこのガイド部63は、下面の前端部が下方に折り曲げられた形状であり、この折り曲げられた部分の前方に、通路65と繋がる下向きの開口66が設けられている。さらにガイド部63は、後面に、通路65と繋がる後ろ向きの開口67が設けられている。
 ここで、前側の開口66を前側開口66と呼び、後側の開口67を後側開口67と呼ぶ。
 この内針ガイド部5Eは、ガイド部63の前端部分がベース5Cの後側壁部53Cより前方に突出した状態で、ガイド部63がベース5Cの切り欠き57に嵌合されることで、ベース5Cに取り付けられる。
 このとき、内針ガイド部5Eの支持部64は、ベース5Cの後側壁部53Cの外側面に当接するようになっていて、これによりガイド部63を、後側壁部53Cと直交するように支持する。
 また、内針ガイド部5Eは、このようにベース5Cに取り付けられたときに、前側開口66が、後側壁部53Cより前方に位置すると共にベース5Cに取り付けられた中心部5Dの外針62の真上に位置するようになっている。
 内針ガイド部5Eの通路65は、後側開口67から前端近傍までの部分が直線状で、それより先の前側開口66までの部分が滑らかなカーブを描いて下方に曲がる曲線状となっている。
 またこの通路65は、中央より前側の部分となる前側通路68と、中央より後側の部分となる後側通路69とでなり、後側通路69が1つの通路であるのに対して、前側通路68は、上下2つの通路68A及び68Bに分かれている。
 ここで、前側通路68の上側の通路68Aを上側通路68Aと呼び、下側の通路68Bを下側通路68Bと呼ぶこととする。これら、上側通路68A及び下側通路68Bは、先端が前側開口66と繋がっていて、後端が後側通路69と繋がっている。
 このうち上側通路68Aは、内針50が通る通路であり、下側通路68Bより太い通路となっている。
 内針50は、後側通路69及び上側通路68A内を通り、上側通路68Aの前端で下方に折り曲げられて前側開口66から下方に延び、中心部5Dの外針62内に挿入されるようになっている。
 さらにこの通路65内には、後側通路69内をスライド可能で、内針50の後端と、薬液貯蔵部6に接続される送出管7Bの前端とを繋げて固定するスライド部70が設けられている。
 実際、このスライド部70が内針ガイド部5Eの後側通路69内を前方にスライドすると、内針50は、これにともなって通路65内を前方に移動し、前側開口66から下方に押し出されるようになっている。
 尚、このスライド部70は、その前端が、上側通路68Aと下側通路68Bとの間の境界部71の後端に当接すると、それ以上前方にスライドできないようになっている。
 つまり、境界部71の後端は、スライド部70のスライドを制限するストッパとして機能するようになっていて、以下、この部分をスライドストッパ71と呼ぶ。
 さらにこのスライド部70は、その下端に、金属製又は樹脂製のベルトでなるベルト部72の後端が固定されている。
 このベルト部72は、後側通路69及び下側通路68B内を通り、下側通路68Bの前端で下方に折り曲げられて前側開口66から下方に延び、その先端が中心部5Dに固定されている。
 中心部5Dとスライド部70は、このベルト部72により連結されていて、これにより、スライド部70が、中心部5Dのスライドに連動してスライドするようになっている。
 実際、押込部5Aに対する押し込み操作により中心部5Dが下方にスライドすると、ベルト部72によりスライド部70が前方にスライドさせられ、内針50も移動する。
 このように、ベルト部72とスライド部70は、押込部5Aに対する押し込み操作による中心部5Dのスライドにともなって、内針50を牽引する内針牽引部73として機能する。
 これにより、中心部5Dが下方にスライドすると、中心部5Dの一部である外針62と、先端がこの外針62内に挿入されている内針50とが共に移動する。
 尚、内針ガイド部5Eは、その側面の一部分が取り外し可能となっていて、この部分を取り外すことで内部を容易に確認できるようになっている。
 また、内針50は、中心部5Dの外針62に挿入されている部分より後端側の部分が、上側通路68A内に挿入可能で且つ内針50の外径より大きい内径を有する管状の内針屈曲防止部74内に挿入されるようにもなっている。
 この内針屈曲防止部74は、詳しくは後述するが、中心部5Dと内針ガイド部5Eの前側開口66との間で、内針50が屈曲してしまうことを防止する樹脂製の部材となっている。
 蓋部5Fは、図9に点線で示すように、ベース5Cの上端部を覆う略四角形の板状でなり、中央前端寄りの位置に、押込部5Aの軸60が通る孔75が設けられている。
 さらに蓋部5Fは、左右両端のそれぞれに、下方に突する板状の突起部76A及び76Bが突設されている。
 蓋部5Fは、押込部5Aの軸60を孔75に通すと共に、左右2つの突起部76A及び76Bを、ベース5Cの左側壁部53A及び53Bのそれぞれの外側面に設けられた2つの上側嵌合溝54C及び54Dに嵌合することで、ベース5Cの上端に固定される。
 尚、この蓋部5Fは、薬液投与装置1の上筐体部3とは別体に設けられて上筐体部3の前端側内部に固定されるようになっていてもよいし、上筐体部3と一体に設けられていてもよい。
 穿刺機構5は、このような構成となっている。ここで、中心部5Dについてより詳しく説明する。
 図13に示すように、中心部5Dは、主として、穿刺針の外針62を有する外針スライド部80と、押込部5Aの軸60に固定され、さらに押込部5Aと外針スライド部80とを固定又は固定解除するスライド固定・解除部81とを有している。
 外針スライド部80は、スライド固定・解除部81の上に重ねられるようになっていて、前側が四角形板状、後側が後方に開口する略コの字型でなり、後側の左右両側面部分がそれぞれ上方に延びた形状となっている。
 この外針スライド部80は、後側の左右両側面部分に凸部82A及び82Bが形成されている。
 凸部82A及び82Bのそれぞれは、ベース5Cのガイド溝55A及び55Bに嵌合される部分であり、これにより外針スライド部80は、ベース5Cのガイド溝55A及び55Bに沿って上下方向にスライドできるようになっている。
 また外針スライド部80は、スライド固定・解除部81の上に重ねられたときに、押込部5Aの軸60と干渉しないよう、前端中央に円弧状の凹部83が設けられている。
 さらに外針スライド部80には、底面中央に、外針62より太く固定板部5Bの連通孔51とほぼ同径の筒状の突起部84が下方に向かって突設されている。
 そしてこの突起部84の下端から、金属製の外針62が下方に向かって延びている。この外針62は中空の管状針となっていて、例えば、長さ8mm、外径0.4mm、内径0.2mmのサイズである。
 さらに外針スライド部80は、突起部84の右側に、突起部84よりも下方への突出量が少ない板状の突起部85が設けられている。
 尚、底面中央の突起部84を中央突起部84と呼び、中央突起部84の右側に位置する突起部85を、右側突起部85と呼ぶ。
 またこの外針スライド部80の上面中央には凹部86が設けられ、この凹部86の中央に、中央突起部84の下端まで達し、外針62と連通する連通孔87が設けられている。
 この連通孔87を介して、内針ガイド部5Eの前側開口66から下方に延びる内針50が、外針62内に挿入されるようになっている。
 さらにこの凹部86に、上述の内針屈曲防止部74の先端が取り付けられている。これにより、内針50は、外針62内に挿入されている部分より後端側の部分が、この内針屈曲防止部74内に挿入されることになる。
 このような構成でなる外針スライド部80は、ベース5Cの内側を、ベース5Cの上端に取り付けられた内針ガイド部5Eと、固定板部5Bとの間で、上下方向にスライド可能となっている。
 実際、この外針スライド部80は、最も上方に位置するときには、後側の左右両側面部分の間に内針ガイド部5Eの前端部の左右両側面を挟み込み、この内針ガイド部5Eの前側開口66の直下に、連通孔87が位置する。
 このとき内針屈曲防止部74は、ほぼ全体が内針ガイド部5Eの上側通路68A内に収まった状態となる。
 さらに、この外針スライド部80は、最も下方に位置するときには、底面の右側突起部85が固定板部5Bの上面に当接すると共に、中央突起部84が、固定板部5Bの連通孔51に嵌入する。
 このとき、中央突起部84は、連通孔51から下方に突出せず、外針62のみが連通孔51から突出する。
 またこのとき、内針屈曲防止部74は、その後端部が、内針ガイド部5Eの上側通路68A内の前端部に残され、残りの部分が、上側通路68A外に露出した状態となる。
 一方、スライド固定・解除部81は、弾性部材でなり、四角形板状の基部88と、この基部88の左右両側面の前端に形成された断面コの字型の爪状ストッパ89A及び89Bとで構成され、基部88の前端中央に押込部5Aの軸60が固定されている。
 またこの基部88の後端に、上述した内針牽引部73のベルト部72の先端が固定されている。
 このように、スライド固定・解除部81の基部88は、押込部5Aと内針牽引部73とに固定される。すなわち、このスライド固定・解除部81を介して、押込部5Aと内針牽引部73とが固定されることになる。
 さらに基部88には、後端寄りの位置に、外針スライド部80の中央突起部84及び外針62を通すための上下方向に貫通する貫通孔90が設けられている。
 一方、左右の爪状ストッパ89A及び89Bは、それぞれ下側爪部91、中央部92、上側爪部93とで構成され、下側爪部91が基部88の側面から延びるようにして基部88と一体成型されている。尚、基部88、爪状ストッパ89A及び89Bと、押込部5Aの軸60が一体成型されるようになっていてもよい。
 この左右の爪状ストッパ89A及び89Bは、通常、下側爪部91の先端より上側爪部93の先端の方が外側に位置するようになっているが、それぞれの外側面を内側に押す力がくわえられると、それぞれの上側爪部93の先端を近づけるように変形する。
 また左右の爪状ストッパ89A及び89Bは、弾性部材であることにより、内側に押す力がなくなれば、それぞれの上側爪部93の先端を遠ざけるように変形して元の形状に戻るようになっている。
 尚、左右の爪状ストッパ89A及び89Bが、上側爪部93を近づける方向に変形することを、爪状ストッパ89A及び89Bが閉じるとし、遠ざける方向に変形することを、爪状ストッパ89A及び89Bが開くとする。
 この爪状ストッパ89A及び89Bは、閉じたときに、上側爪部93が、基部88の上面より所定長だけ上方に位置するようになっている。
 ここで、スライド固定・解除部81の連通孔87に、外針スライド部80の中央突起部84を嵌入して、スライド固定・解除部81の上に外針スライド部80を重ねるとする。
 ここで、スライド固定・解除部81の厚さは、外針スライド部80の中央突起部84の突出量より薄く形成されていて、これにより、重ねられたときに、この中央突起部84の先端部が外針62と共に、スライド固定・解除部81の貫通孔90より下方に突出するようになっている。
 この下方に突出した中央突起部84の先端部が、固定板部5Bの連通孔51に嵌入される部分となる。
 さらに、このように、スライド固定・解除部81の上に外針スライド部80を重ねた状態で、左右の爪状ストッパ89A及び89Bを閉じると、左右の爪状ストッパ89A及び89Bの上側爪部93と基部88の上面との間に、外針スライド部80が挟み込まれることで、スライド固定・解除部81に外針スライド部80が固定される。
 このようにして、スライド固定・解除部81に外針スライド部80が固定されるようになっている。ここで、このスライド固定・解除部81は、押込部5Aとも固定されていることから、スライド固定・解除部81に外針スライド部80が固定されるということは、このスライド固定・解除部81を介して、押込部5Aと外針スライド部80が固定されることを意味する。
 さらにこの状態から、左右の爪状ストッパ89A及び89Bが開くと、スライド固定・解除部81と外針スライド部80との固定が解除される(すなわち、押込部5Aと外針スライド部80との固定が解除される)ようになっている。
 このような構成でなる中心部5Dは、スライド固定・解除部81の上に外針スライド部80を重ね、外針スライド部80の外針62内に内針50を挿入した状態で、ベース5Cの内側のガイド溝55A及び55Bに、外針スライド部80の凸部82A及び82Bを嵌合させることで、ベース5Cの内側に嵌入される。
 この中心部5Dは、図14(A)に示すように、初期位置としてベース5Cの内側上端に配置される。尚、図14は、説明の都合上、穿刺機構5の一部(ボタン61、コイルバネなど)を省略したものである。
 このとき、中心部5Dは、外針スライド部80の連通孔87が、内針ガイド部5Eの前側開口66の直下に位置していて、内針ガイド部5Eにより下方に折り曲げられた内針50の先端部が、この連通孔87を介して外針62内に挿入されている。
 またこのとき、外針62の全体が薬液投与装置1内に収納されている一方で、押込部5Aの薬液投与装置1からの突出量は最大となっている。
 さらにこのとき、中心部5Dは、ベース5Cの左側壁部53A及び右側壁部53Bの上端に位置していて、図15(A)に示すように、左右の爪状ストッパ89A及び89Bの外側に、開くスペースとしての上側凹部56A及び56Bが位置していることで、図14(B)にも示すように、左右の爪状ストッパ89A及び89Bが開いた状態となっている。尚、図15は、説明の都合上、穿刺機構5の一部(押込部5Aなど)を省略すると共に、外針スライド部80の形状をデフォルメしたものである。
 すなわち、中心部5Dは、初期位置に在るときには、まだスライド固定・解除部81に外針スライド部80を固定していない。
 さらにこの初期位置に在るとき、中心部5Dの外針スライド部80は、図15(A)に示すように、ベース5Cの後側壁部53Cに設けられたバネ折返部59の上端前方に位置するようになっている。
 ここで、ベース5Cの後側壁部53Cの左寄りの下端に設けられたバネ固定部58に一端を固定されたコイルバネ94は、他端側がバネ折返部59により下方に折り曲げられJ字型となった状態で、他端を外針スライド部80の後部右寄りの所定位置に固定されるようになっている。
 このときのコイルバネ94は、伸縮していない自然長の状態である。そして、この状態から、使用者が押込部5Aを薬液投与装置1内に押し込んでいくとする。
 すると、中心部5Dは、まず、スライド固定・解除部81の左右の爪状ストッパ89A及び89Bがベース5Cの上側凹部56A及び56Bを外れて左側壁部53A及び右側壁部53Bにより内側に押圧されることで閉じる。
 これによりスライド固定・解除部81に外針スライド部80が固定された状態となり、中心部5Dは、この状態で、図15(B)に示すように、ベース5Cの内側を下方にスライドしていく。
 またこのとき、中心部5Dの外針スライド部80が下方にスライドしていくことにともなって、J字型からU字型へと変形するようにしてコイルバネ94全体が伸びていくようになっている。
〔6.穿刺機構の動作〕
 ここで、実際に、穿刺針である外針62と内針50を使用者の体内に穿刺するときの穿刺機構5の動作について詳しく説明する。
 穿刺機構5は、まず図14(A)に示したように、中心部5Dが初期位置にセットされていて、外針62の全体が薬液投与装置1内に収納されていると共に、押込部5Aの薬液投与装置1からの突出量が最大となっている。
 このとき、中心部5Dは、図15(A)に示したように、左右の爪状ストッパ89A及び89Bの外側に、左側壁部53A及び右側壁部53Bの上端に設けられた上側凹部56A及び56Bが位置することで、図14(B)にも示すように、左右の爪状ストッパ89A及び89Bが開いていて、スライド固定・解除部81に外針スライド部80を固定していない。
 またこのとき、内針50は、図19(A)に示すように、その先端が外針62の先端とほぼ同位置で且つ外針62の先端から突出しない位置を保つようにして外針62の内側に挿入されている。
 ここで、使用者が薬液投与装置1を身体の所定位置に貼り付けた後、押込部5Aを薬液投与装置1内に押し込んでいく。
 すると、図15(B)及び図16(A)に示すように、中心部5Dがベース5Cの内側を下方にスライドすることになる。ここで、左右の爪状ストッパ89A及び89Bは、上側凹部56A及び56Bから外れることで、外側に開くスペースがなくなり、左側壁部53A及び右側壁部53Bにより内側に押圧されることで閉じる。
 これにより、図16(B)に示すように、スライド固定・解除部81に外針スライド部80が固定され、押込部5Aと外針スライド部80とが固定されたことになる。そして、これ以降、外針スライド部80は、押込部5Aの押し込みにともなって、スライド固定・解除部81と共に下方にスライドしていく。
 このように、中心部5Dは、スライド固定・解除部81に外針スライド部80を固定しない状態で初期位置に設けられ、押込部5Aが押し込まれると、まずスライド固定・解除部81の爪状ストッパ89A及び89Bが閉じてスライド固定・解除部81に外針スライド部80を固定し、その後、スライド固定・解除部81に外針スライド部80を固定した状態で下方にスライドしていくようになっている。
 また、このように押込部5Aと共に中心部5Dが下方にスライドすることにともなって、この中心部5Dのスライド固定・解除部81に固定されたベルト部72が、内針ガイド部5E内のスライド部70を前方にスライドさせることで、内針50を牽引する。
 これにより、内針50は、その先端が外針62の先端とほぼ同位置で且つ外針62の先端から突出しない位置を保ったまま、確実に、外針62と共に移動する。
 また、このようにして押込部5Aと共に中心部5Dが下方にスライドすると、内針ガイド部5Eと中心部5Dとの間隔が広がり、この範囲で内針50が内針ガイド部5Eの外に露出することになる。
 ここで、内針50全体のうち、内針ガイド部5Eと中心部5Dとの間に位置する部分は、ガイドするものがなければ、中心部5Dのスライドにともなって屈曲してしまう恐れがある。
 そこで、本実施の形態の穿刺機構5では、この部分が内針屈曲防止部74内に挿入されることで保護されるようになっている。
 換言すれば、この内針屈曲防止部74は、内針50全体のうち、内針ガイド部5Eと中心部5Dとの間に位置する部分をガイドするようになっていて、これにより、この部分が屈曲してしまうことを防ぐようになっている。
 さらに、このようにして押込部5Aと共に中心部5Dが下方にスライドする間、図15(B)に示すように、中心部5Dの外針スライド部80に他端が固定されたコイルバネ94が伸びていく。
 ここで、中心部5Dの外針62は、内針50を内側に保持したまま、下方にスライドして、固定板部5Bの連通孔51を通り穿刺針孔2Bから突出することで、内針50と共に使用者の体内に穿刺される。
 さらに押込部5Aが押し込まれて、図15(C)及び図17(A)に示すように、押込部5Aの軸60全体が薬液投与装置1内に収納されると、このとき押込部5Aは、薬液投与装置1から突出している部分がボタン61のみとなり突出量が最小となる。
 このようにして押込部5Aが最後まで押し込まれると、このとき中心部5Dは、ベース5Cの下端に到達する。このとき、穿刺針である外針62と内針50は、図19(B)に示すように、使用者の体内に最も深く穿刺される。尚、薬液投与装置1では、使用者の体内に穿刺される部分の長さが例えば7mmとなるように設計されている。
 またこのとき、中心部5Dの爪状ストッパ89A及び89Bの外側に、左側壁部53A及び53Bの下端に設けられた下側凹部56C及び56Dが位置することで、爪状ストッパ89A及び89Bは、図17(B)に示すように、内側に押圧される力がなくなり開く。
 この結果、中心部5Dのスライド固定・解除部81と外針スライド部80との固定が解除され、押込部5Aと外針スライド部80との固定が解除されたことになる。
 このようにして固定が解除されると、外針スライド部80は、コイルバネ94の復元力により、図15(D)、図18(A)及び(B)に示すように、上方にスライドして元の位置に戻る。
 これにより、外針62の全体が使用者の体内から引き抜かれて薬液投与装置1内に収納される。このとき、内針50については、スライド固定・解除部81と固定されている内針牽引部73により位置が保持されることで、図19(C)に示すように、そのまま使用者の体内に留置する。
 また、このようにして、外針スライド部80が上方にスライドする場合も、内針50全体のうち、少なくとも、内針ガイド部5Eと中心部5Dの間に位置する部分は、内針屈曲防止部74に覆われ、ガイドされる。
 これにより、この部分が、外針スライド部80のスライドにともなって、屈曲してしまうことを防ぐようになっている。
 また、このように、内針50が内針ガイド部5Eと外針スライド部80との間で屈曲してしまうことを防ぐことにより、内針50が使用者の体内から抜けてしまったり、使用者の体内に留置する部分が短くなってしまったりすることを防ぐこともできる。つまり、より確実に内針50を使用者の体内に穿刺することができると言える。
 このように穿刺機構5は、押込部5Aの押し込み操作に応じて、使用者の体内に外針62と共に内針50を穿刺し、中心部5Dがベース5Cの下端に到達するまで押込部5Aが押し込まれると、すなわち押込部5Aが最後まで押し込まれると、内針50を体内に留置させたまま、外針62のみを引き戻すようになっている。
 尚、薬液投与装置1は、押込部5Aが最後まで押し込まれたときに押込部5Aのボタン61が上筐体部3の蓋となり、且つ押込部5Aの軸60周りにパッキン(図示せず)が設けられていることにより、内部に水が入らない防水構造となっている。
 ここまで説明したように、薬液投与装置1は、使用者により押込部5Aが押し込まれると、外針62を有する中心部5Dが下方にスライドすると共に、中心部5Dを介して押込部5Aに固定された内針牽引部73が内針50を牽引することで、外針62と、この外針62内に挿入された内針50とを、薬液投与装置1から突出させて、使用者の体内に穿刺する。
 そして、薬液投与装置1は、押込部5Aが最後まで押し込まれると、中心部5Dの爪状ストッパ89A及び89Bが開き、中心部5Dの外針スライド部80のみをコイルバネ94の復元力により元の位置に戻すことで、内針50を使用者の体内に留置させたまま、外針62のみを薬液投与装置1内に引き戻す。
 その後、薬液投与装置1は、薬液貯蔵部6に貯蔵されている薬液を、送出部8により、内針50を介して使用者の体内に投与する。
 このように、薬液投与装置1は、二重構造でなる穿刺針の内針50を留置針とすることで、外針62を留置針とする従来の穿刺針と比して、留置針の径を容易に小さくすることができる。
 すなわち、薬液投与装置1は、使用者の体内に留置する部分である留置針としての内針50を細くでき、これにより使用者に対する負担を軽減することができる。
 因みに、樹脂材料でなる内針50は、肉薄管での製造が可能であり、同じ外径の金属針と比較して内径を大きくすることができる。
 また薬液投与装置1は、押込部5Aに対する押し込み操作のみで、穿刺針(外針62及び内針50)の穿刺から外針62の引き戻しまでを一度に行うことができる。
 またこのように薬液投与装置1の穿刺機構5は、使用者の押し込み操作のみで動作するので、モータなどの駆動部を必要とせず、構成を簡易化でき、容易に小型化することができる。
 また、薬液投与装置1は、主として、押込部5Aと、外針スライド部80と、スライド固定・解除部81と、内針牽引部73と、コイルバネ94とで、穿刺機構5に必要な機能(穿刺針の穿刺と外針62の引き戻し)を実現するようにしたことで、結果として、部品点数を抑えつつ、穿刺機構5に必要な機能を実現できるようになっている。
 さらに薬液投与装置1は、穿刺時に、押込部5Aの押し込みによる外針スライド部80のスライドにともなって、外針スライド部80を介して押込部5Aに固定された内針牽引部73により内針50を牽引するようにしたことで、内針50を外針62と共に確実に移動させることができる。
 これにより、例えば、外針62のみが移動して、外針62のみが使用者の体内に穿刺されるような状況を防ぎ、外針62と共に内針50を確実に使用者の体内に穿刺することができる。
 さらに薬液投与装置1は、押込部5Aが最後まで押し込まれると、全体として突起部分の少ないコンパクトなサイズとなり、携帯時の利便性を向上させるようにもなっている。
〔7.薬液投与装置の電気的構成〕
 薬液投与装置1は、図20に示すように、CPU(Central Processing Unit)101、ROM(Read Only Memory)102、RAM(Random Access Memory)103、電源部104、インターフェース部(I/F部)105、報知部106及び駆動部9がバス107を介して接続される。
 CPU101、ROM102、RAM103、電源部104及び報知部106は、基板部10上に配される。電源部104は電池が適応される。報知部106はスピーカが適応される。
 インターフェース部105は、上筐体部3又は下筐体部2に配されユーザの入力命令を受け付けるボタン(図示せず)が適応される。
 CPU101は、ROM102に格納された基本プログラムをRAM103に読み出して実行することより全体を統括制御すると共に、ROM102に記憶された各種アプリケーションプログラムをRAM103に読み出して実行することにより各種処理を実行する。
 CPU101は、薬液を使用者に投与する際、薬液投与プログラムをRAM103に読み出して薬液投与処理を実行し、薬液が外部から薬液貯蔵部6に充填され、貼付部4が使用者の皮膚に貼り付けられると共に穿刺機構5により穿刺針が使用者の皮膚に穿刺された後、インターフェース部105を介して入力された投与量、投与速度などのパラメータを設定する。
 そしてCPU101は、設定されたパラメータに基づいて駆動部9を制御して薬液の投与を開始する。
〔8.他の実施の形態〕
〔8−1.他の実施の形態1〕
 上述した実施の形態では、使用者の体内に薬液を投与する薬液投与装置1に本発明を適用する場合について説明した。これに限らず、外針と内針とでなる二重構造の穿刺針を穿刺する穿刺装置であれば、薬液投与装置1以外の装置に適用するようにしてもよい。
 例えば、使用者の体内に各種センサを挿入して生体情報を取得するセンサ装置に適用するようにしてもよい。
 図21に、このセンサ装置200を示す。このセンサ装置200は、薬液投与装置1と同様の穿刺機構5を有している一方で、薬液貯蔵部6や、送出部8、駆動部9が無く、代わりにセンサからの生体情報を取得する制御部201と、この生体情報を外部に無線送信する送信部202とを有している。
 また図22に示すように、このセンサ装置200の内針50の先端にはセンサ203が取り付けられていて、さらにこの内針50内には、センサ203と制御部201とを電気的に接続する信号線204が挿入されている。
 そしてこのセンサ装置200では、穿刺機構5により、先端部にセンサ203が取り付けられた内針50が挿入された外針62を、使用者の体内に穿刺する。
 そして、このセンサ装置200は、センサ203を使用者の体内に留置させたまま、外針62のみをセンサ装置200内に引き戻す。
 その後、センサ装置200の制御部201は、センサ203から得られる生体情報を取得し、送信部202を介して外部に無線送信する。
〔8−2.他の実施の形態2〕
 上述した実施の形態では、図9~図13に示した穿刺機構5により、穿刺針(外針62及び内針50)を使用者の体内に穿刺して、外針62のみを引き戻すようにしたが、図9~図13に示した穿刺機構5以外の穿刺機構により、穿刺針の穿刺と外針の引き戻しを行うようにしてもよい。
〔8−3.他の実施の形態3〕
 また、上述した実施の形態では、金属製の外針62と樹脂製の内針50とでなる穿刺針を使用者の体内に穿刺した後、外針62のみを薬液投与装置1内に引き戻すための弾性部材としてコイルバネ94を用いるようにしたが、これに限らず、コイルバネ94と同様に機能する弾性部材であれば、コイルバネ94以外の弾性部材を用いようにしてもよい。
〔8−4.他の実施の形態4〕
 さらに、上述した実施の形態では、穿刺機構5に、中心部5Dと、内針ガイド部5Eの前側開口66との間で、内針50を覆う内針屈曲防止部74を設けるようにしたが、これに限らず、穿刺機構5を、この内針屈曲防止部74を省略した構成としてもよい。
〔8−5.他の実施の形態5〕
 さらに、上述した実施の形態では、穿刺機構5の内針牽引部73を、ベルト状のベルト部72とスライド部70とで構成するようにした。
 これに限らず、ベルト部72の変わりに、例えば、金属製又は樹脂製のワイヤでなるワイヤ部と、スライド部70とで内針牽引部73を構成するようにしてもよい。
 この場合、ワイヤ部の先端をスライド固定・解除部81に固定すると共に、後端をスライド部70に固定するようにすればよい。
 また、これに限らず、ベルトやワイヤのように自由に折り曲げることが可能で伸縮せず、且つスライド固定・解除部81とスライド部70とを、これらの距離が常に一定となるように連結可能なものであれば、ベルトやワイヤ以外の部材を用いるようにしてもよい。
Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.
[1. Overall configuration of drug solution administration device]
As shown in FIG. 1 and FIG. 2, the drug solution administration device 1 is a portable device that is used by being attached to the skin of a user, and is a bottom device that is open on the upper side and has a space inside. A flat, substantially rectangular parallelepiped shape is formed by the casing 2 and the upper casing 3 that fits into the opening of the lower casing 2.
The size of the drug solution administration device 1 may be reduced to such an extent that it can be affixed to the user's skin, and examples thereof include a substantially rectangular parallelepiped shape having a width of 32 mm, a length of 44 mm, and a height of 11 mm.
The lower housing part 2 is provided with a sticking part 4 made of double-sided tape or the like on the bottom surface 2A. The medicinal-solution administration device 1 is held by the user when the affixing portion 4 is affixed to the user's skin.
The medicinal-solution administration device 1 is a puncture needle (not shown) that is punctured into the user's body in order to administer insulin filled therein to the front end of the bottom surface 2A of the lower housing part 2. Is provided with a puncture needle hole 2 </ b> B for allowing the puncture mechanism 5 to project from the space formed by the lower housing portion 2 and the upper housing portion 3. The puncture needle has a double structure including a metal outer needle and a resin inner needle, which will be described in detail later.
In addition, the medicinal solution administration device 1 is provided with a pushing portion 5 </ b> A capable of pushing operation at the front end of the upper housing portion 3. The pushing portion 5A is a part of the puncture mechanism 5 shown in FIG. 2, and the drug solution administration device 1 is punctured from the puncture needle hole 2B by operating the puncture mechanism 5 when the push portion 5A is pushed into the user. The puncture needle is punctured into the user's body by protruding the needle.
Furthermore, the chemical solution administration device 1 is provided with a chemical solution storage unit 6, a flow channel unit 7, a delivery unit 8, a drive unit 9, a substrate unit 10, and the like in a space formed by the lower casing unit 2 and the upper casing unit 3. .
As will be described in detail later, the chemical solution storage unit 6 is filled with a chemical solution from the outside in a cylindrical outer cylinder 11.
The flow path part 7 includes suction pipes 7A, a delivery pipe 7B, flow paths 22B, 23A, 24A formed in the delivery part 8 and an inner needle of a puncture needle of the puncture mechanism 5, and a chemical solution from the drug solution storage part 6 to the body. Forms a flow path through which. The suction pipe 7A allows the chemical solution storage unit 6 and the flow path 23A formed in the delivery unit 8 to communicate with each other. The delivery tube 7B allows the flow path 24A formed in the delivery unit 8 to communicate with the inner needle of the puncture needle of the puncture mechanism 5.
As will be described in detail later, the delivery unit 8 allows the chemical solution stored in the chemical solution storage unit 6 to flow through the flow path unit 7 when the piston 21 slides in the internal space 22A of the cylinder unit 22 (FIG. 4). To be delivered to the body.
The drive unit 9 drives the piston 21 based on the control of the CPU 101 (FIG. 18), and slides the piston 21 in the internal space 22 </ b> A of the cylinder unit 22.
The substrate unit 10 is provided with a power source unit 104 (FIG. 18) for supplying power and a circuit such as a CPU 101.
[2. (Composition of chemical storage part)
The chemical | medical solution storage part 6 inserts piston 12 from the open end side to the outer cylinder 11 formed in a cylindrical shape, as shown in FIG. The chemical liquid storage unit 6 stores the chemical liquid in a chemical liquid storage space 13 formed by the outer cylinder 11 and the piston 12.
The outer cylinder 11 is provided with a distal end portion 11B that closes the distal end of the cylindrical main body portion 11A, and the main body portion 11A and the distal end portion 11B are integrally formed.
The tip portion 11B is a surface (hereinafter referred to as an inscribed surface) that is in contact with the medicinal solution storage space 13 along a direction orthogonal to a direction along the axis of the main body portion 11A (hereinafter also referred to as a cylinder axis direction). A hollow protrusion 11D having an opening penetrating to the outside is provided at the center of 11C.
The distal end portion 11B communicates with the protruding portion 11D, and an external port 11E protrudes in a direction opposite to the protruding portion 11D. The suction pipe 7A is connected to the external port 11E.
The main body 11 </ b> A is provided with a regulating portion 11 </ b> F in which a portion longer than the length of the protruding portion 11 </ b> D protrudes inward from the inscribed surface 11 </ b> C on the inner peripheral surface in contact with the chemical solution storage space 13. That is, the main body portion 11A is formed such that the inner diameter of the restricting portion 11F is shorter than the inner diameter of the main body portion 11A other than the restricting portion 11F.
The piston 12 is inserted into the outer cylinder 11 from the end opposite to the distal end portion 11B, contacts the inner surface of the main body portion 11A along the circumferential direction, and is liquid-tight along the cylindrical axis direction of the main body portion 11A. It is slidably arranged. The piston 12 is formed with a diameter larger than the inner diameter of the restricting portion 11F.
The medicinal solution storage unit 6 is configured such that the medicinal solution stored in the vial from a predetermined injection port (not shown) enters the medicinal solution storage space 13 in a state where the piston 12 is positioned closest to the tip end part 11B and is in contact with the regulating unit 11F. Injected. At this time, in the chemical solution storage unit 6, a slight space is opened by the regulating unit 11 </ b> F between the inscribed surface 11 </ b> C of the outer cylinder 11 and the piston 12.
In the chemical solution storage unit 6, the piston 12 is moved to the end side as the chemical solution is injected, and a predetermined amount (for example, 2 ml) of the chemical solution is injected. At this time, bubbles that existed in the chemical solution storage space 13 remain as they are.
When the chemical solution is delivered into the body by the delivery unit 8, the chemical solution storage unit 6 sucks in through the protrusion 11 </ b> D and the external port 11 </ b> E while the piston 12 moves to the tip portion 11 </ b> B side by the chemical solution suction pressure by the delivery unit 8. The chemical solution is sent to the tube 7A. And the chemical | medical solution storage part 6 sends out a chemical | medical solution until the piston 12 contact | abuts to protrusion part 11D.
By the way, in the chemical | medical solution storage part 6, when the bubble exists in the chemical | medical solution storage space 13, most of this bubble adheres to a wall surface. Therefore, in the chemical solution storage unit 6, when the piston 12 moves and the chemical solution is delivered, the bubbles attached to the side surface of the main body portion 11A move while being pushed by the piston 12, and the piston 12 comes into contact with the regulating portion 11F. At this time, since the air bubbles are accumulated in the space provided between the piston 12 and the inscribed surface 11C, it is possible to prevent the air bubbles from being sent to the outside.
Further, since the chemical liquid storage unit 6 is provided with the protruding portion 11D protruding from the inscribed surface 11C on the chemical liquid storage space 13 side, bubbles attached to the side surface of the main body 11A when the chemical liquid is delivered. Can be prevented from being sent to the outside through the opening of the protrusion 11D.
[3. (Configuration of sending unit)
As shown in FIG. 4A, the delivery unit 8 includes a piston 21, a cylinder unit 22, lids 23 and 24, one-way valves 25 and 26, an X ring 27, an X ring fixing unit 28, and a fixing member 29. It is supposed to be configured.
The piston 21 has a diameter of, for example, 1.03 mm, and is slid with a predetermined stroke in an internal space 22 </ b> A formed in a hollow cylindrical shape formed in the cylinder portion 22 by being driven by the drive portion 9. Examples of the material of the piston 21 include stainless steel, copper alloy, aluminum alloy, titanium material, thermoplastic elastomer such as polypropylene and polycarbonate, and the like.
The cylinder portion 22 is provided with an internal space 22A in which the piston 21 is inserted from one end and slides. The cylinder portion 22 is provided such that a flow path 22B that is in contact with the other end of the internal space 22A and orthogonal to the internal space 22A penetrates between opposing side surfaces of the cylinder portion 22.
The cylinder part 22 is provided with an X ring 27 for preventing leakage of a chemical solution between the piston 21 and an X ring fixing part 28 for fixing the X ring 27 at one end where the piston 21 is inserted in the internal space 22A.
The X ring 27 is inserted into the cylinder portion 22 from the side of the cylinder portion 22 where the internal space 22A is provided, and is pressed and fixed by the X ring fixing portion 28. A part of the X ring fixing part 28 is fitted into the cylinder part 22 and the X ring 27 is fixed so that the remaining part is exposed to the outside.
As shown in FIG. 4B, the flow path 22B is formed in a rectangular cross section whose horizontal width is the same as the diameter of the internal space 22A and whose height is shorter than the horizontal width. Hydrophilic processing is performed on the surfaces of the internal space 22A and the flow path 22B. As the hydrophilic processing, for example, plasma treatment or application of a surfactant (sodium stearate) or the like is applied. Note that hydrophilic processing may also be performed on the tip surface (upper surface) of the piston 21.
In the cylinder portion 22, the diameter of the internal space 22A and the horizontal width of the flow path 22B are formed to have the same length, and the center position of the axis of the internal space 22A and the central position of the horizontal width of the flow path 22B are formed to coincide.
The cylinder portion 22 has lid portions 23 and 24 connected to the side surface on which the flow path 22B is formed via a fixing member 29, respectively. The lid portions 23 and 24 are provided with flow passages 23A and 24A penetrating along the flow passage 22B at positions facing the flow passage 22B of the cylinder portion 22.
One end of the flow path 23A is connected to the flow path 22B of the cylinder part 22, and the other end of the flow path 23A is connected to the suction pipe 7A to connect the suction pipe 7A and the flow path 22B.
In the lid 24, one end of the flow path 24A is connected to the flow path 22B of the cylinder part 22, and the other end of the flow path 24A is connected to the delivery pipe 7B, thereby communicating the flow path 22B and the delivery pipe 7B.
The delivery section 8 is provided with a one-way valve 25 between the flow path 23A of the lid section 23 and the flow path 22B of the cylinder section 22, and between the flow path 22B of the cylinder section 22 and the flow path 24A of the lid section 24. Is provided with a one-way valve 26.
The one-way valve 25 allows the chemical liquid flowing from the flow path 23A of the lid portion 23 to the flow path 22B of the cylinder portion 22 to pass, and does not allow the chemical liquid to pass from the flow path 22B of the cylinder portion 22 to the flow path 23A of the lid portion 23. For example, an umbrella valve is applied.
The one-way valve 26 allows the chemical liquid that flows from the flow path 22B of the cylinder portion 22 to the flow path 24AB of the lid portion 24 to pass, and does not allow the chemical liquid to pass from the flow path 22B of the cylinder portion 22 to the flow path 24A of the lid portion 24. For example, an umbrella valve is applied.
The delivery unit 8 is a position where the piston 21 is most retracted (hereinafter also referred to as a push-off position) when delivering a chemical solution from the chemical solution storage unit 6 into the living body (hereinafter also referred to as a withdrawal position). The chemical solution that has been moved by the drive unit 9 in the internal space 22A and stored in the chemical solution storage unit 6 is sucked into the internal space 22A.
And the delivery part 8 sends out the chemical | medical solution suck | inhaled by 22 A of internal spaces in the living body, when the piston 21 is moved by the drive part 9 from a retracted position to a pushing position.
The delivery unit 8 can administer about 1 to 2 μL of a chemical solution into the user's body by reciprocating the piston 21 once. By repeating this operation at a set cycle and interval, a desired administration rate and dosage can be obtained. The drug solution can be administered to the user.
By the way, the pressing position is set to a position where the tip of the piston 21 is on the same plane as the bottom surface of the flow path 22B (the surface to which the internal space 22A is connected) or a position within the flow path 22B. That is, as shown in FIG. 5, when the drive unit 9 moves the piston 21 to the pressing position, the position where the tip of the piston 21 is on the same plane as the bottom surface of the flow path 22B or within the flow path 22B from the position. Move to the position.
As a result, when air bubbles are present in the internal space 22A, the delivery unit 8 causes the air bubbles present in the internal space 22A to move into the flow path 22B at the tip surface (upper surface) of the piston 21 when the piston 21 moves to the push-off position. Since it can push out, when the piston 21 is moved to the retracted position thereafter, the possibility that the bubbles are pulled back into the internal space 22A can be greatly reduced.
On the other hand, in an apparatus that does not move the piston tip into the flow path, for example, bubbles adhere to the side surface of the cylinder part that contacts the internal space or the tip surface of the piston, and the air bubbles present in the internal space cause the piston to slide. In some cases, it may not be pushed into the flow path.
In this case, the bubble repeatedly expands and contracts due to a change in the internal pressure that changes according to the movement of the piston, thereby changing the amount of the drug solution sucked into the internal space, and sending the set drug solution amount into the living body. Can not do. Therefore, with such a device, there is a possibility that the drug solution cannot be administered with high accuracy.
On the other hand, since the drug solution administration device 1 pushes out the air bubbles existing in the internal space 22A into the flow path 22B when the piston 21 moves to the push-off position in the delivery unit 8, the piston 21 moves to the retract position thereafter. In doing so, only the chemical solution can be sucked into the internal space 22A. Thus, the drug solution administration device 1 can accurately administer the drug solution.
Further, in the drug solution administration device 1, since the hydrophilic processing is applied to the front end surface of the piston 21, and the surfaces of the internal space 22A and the flow path 22B, it is possible to prevent air bubbles from remaining in the internal space 22A and the flow path 22B. can do.
[4. (Configuration of drive unit)
As shown in FIG. 6, the drive unit 9 includes a base unit 31, a motor 32, a motor support unit 34, a motor fixing plate 35, a fixed plate support unit 36, a bearing unit 37, a coupling 38, and a bearing support unit 39. It is said.
Each part of the drive unit 9 is arranged on the base unit 31. The motor 32 is sandwiched between a motor support portion 34 and a motor fixing plate 35 supported by the fixing plate support portion 36 and fixed to the base portion 31.
The motor 32 is provided with a motor shaft 33 that protrudes from the side surface on the motor fixing plate 35 side. A screw groove 33 </ b> A is formed on the side surface of the motor shaft 33.
The bearing portion 37 has a substantially rectangular parallelepiped shape that is elongated along the axial direction of the motor 32 and has a hollow interior. The bearing portion 37 is provided with a screw hole 37A at the center of the side surface corresponding to the short side of the substantially rectangular parallelepiped shape, through which the motor shaft 33 of the motor 32 is inserted and screwed into the screw groove 33A.
In the bearing portion 37, the piston 21 is coaxially connected to the motor shaft 33 via a coupling 38 on a side surface facing a side surface provided with a screw hole 37 </ b> A corresponding to a short side of a substantially rectangular parallelepiped shape. The bearing portion 37 is supported by the bearing support portion 39. As the coupling 38, for example, a coupling that absorbs axial displacement between the motor shaft 33 and the piston 21 is applied.
As shown in FIGS. 6 and 7, the drive unit 9 rotates the motor shaft 33 when the motor 32 is driven, and the bearing unit 37 screwed to the motor shaft 33 in the axial direction is driven in accordance with the rotation. Move and reciprocate the piston 21 in the axial direction. As a result, the drive unit 9 slides the piston 21 in the internal space 22 </ b> A of the cylinder unit 22. 6A and 6B, the piston 21 is in the retracted position, and in FIG. 7, the piston 21 is in the push-off position.
Thus, since the motor shaft 33 of the motor 32 is arranged coaxially with the piston 21, the drive unit 9 has a force applied to the bearing portion 37 by the rotation of the motor shaft 33 and the force applied to the piston 21. The applied force is in the same direction, and the thrust loss of the piston 21 is eliminated.
Therefore, the drive unit 9 can slide the piston 21 with a stable stroke distance in the internal space 22 </ b> A of the cylinder unit 22. In addition, since the driving unit 9 can drive the piston 21 with a smaller force by eliminating the loss of thrust of the piston 21, the motor 32, the battery, and the like can be reduced, and the entire apparatus can be downsized. Can do. The side surface of the piston 21 may be coated with diamond-like carbon to reduce sliding resistance.
On the other hand, in a device in which the piston and the shaft portion of the motor are not arranged coaxially, the force applied to the bearing portion by the rotation of the shaft portion and the force applied to the piston by the force are offset, The loss of thrust of the piston increases, and the sliding resistance of the bearing portion and the piston increases due to the offset of the force, which not only stabilizes the stroke of the piston but also increases the size of the entire apparatus.
By the way, in the chemical solution administration device 1, as shown in FIG. 8, the space between the X ring fixing portion 28 and the coupling 38 is covered with a tube-like flexible film 40. As the material of the film 40, for example, polyethylene or the like is applied.
The film 40 is fixed to the X ring fixing portion 28 and the coupling 38 without gaps in the circumferential direction by film fixing portions 41 and 42 having both ends made of, for example, O-rings.
Since the film 40 has flexibility, the piston 21 is always in the range from the state where the piston 21 shown in FIG. 8A is in the retracted position to the state where the piston 21 shown in FIG. Can be kept covered.
Therefore, in the chemical solution administration device 1, the piston 21 can be slid within the internal space 22 </ b> A of the cylinder portion 22 without touching the air outside the film 40. Thereby, the chemical solution administration device 1 can further maintain the cleanliness of the piston 21 entering the internal space 22A.
[5. (Puncture mechanism configuration)
Next, the configuration of the puncture mechanism 5 will be described in detail. As shown in FIG. 9, the puncture mechanism 5 mainly includes a pushing portion 5A, a fixing plate portion 5B fixed to the inside of the front end side of the bottom surface 2A (FIG. 1) of the lower housing portion 2, and the fixing plate portion 5B. A base 5C projecting from the base 5C, a central portion 5D that can be slid in the vertical direction inside the base 5C in response to a pressing operation on the pressing portion 5A, and an inner needle 50 that guides the inner needle 50 from the rear of the base 5C to the inside of the base 5C. An inner needle guide portion 5E to be attached, and a lid portion 5F attached to the upper end of the base 5C. In FIG. 9, the lid 5F is indicated by a dotted line.
As shown in FIG. 10, the fixed plate portion 5 </ b> B has a substantially square plate shape, and a communication hole 51 that communicates with the puncture needle hole 2 </ b> B provided in the bottom surface 2 </ b> A of the lower housing portion 2 is provided at the center thereof. Yes.
Further, plate-like projections 52A and 52B are provided on the left and right sides of the communication hole 51 at a predetermined interval.
The fixing plate 5B may be provided separately from the lower casing 2 of the drug solution administration device 1 and fixed to the lower casing 2 or the lower casing 2 And may be provided integrally.
As shown in FIGS. 10 and 11, the base 5C has a substantially U-shaped cross section having three walls 53A, 53B, and 53C on the left and right and rear sides, and the left wall 53A and the right wall 53B. On the outer side of each of these, fitting grooves 54A and 54B into which the protrusions 52A and 52B of the fixing plate portion 5B are fitted are provided at the center lower part thereof.
The base 5C is fixed at a predetermined position of the fixed plate portion 5B by fitting the projections 52A and 52B of the fixed plate portion 5B into these two fitting grooves 54A and 54B.
Further, on the outer side surfaces of the left side wall part 53A and the right side wall part 53B, the fitting parts 54F and 54B are fitted above the center of the fitting grooves 54A and 54B, that is, in the center upper part, respectively. Grooves 54C and 54D are provided.
Here, the lower fitting grooves 54A and 54B are referred to as lower fitting grooves 54A and 54B, and the upper fitting grooves 54C and 54D are referred to as upper fitting grooves 54C and 54D.
Furthermore, a groove 55A and a groove 55B (FIG. 10) extending from the lower end to the upper end are provided on the inner side surfaces of the left wall portion 53A and the right wall portion 53B at positions close to the rear end.
These grooves 55A and 55B are grooves that serve as guides when the central portion 5D slides along the inner wall of the base 5C. Hereinafter, these grooves 55A and 55B are referred to as guide grooves 55A and 55B.
Further, recessed portions 56A and 56B that are recessed outward are provided at the upper ends in front of the guide grooves 55A and 55B on the inner side surfaces of the left side wall portion 53A and the right side wall portion 53B, and the recessed portions 56C and 56D are provided at the lower ends. Is provided.
Here, the recesses 56A and 56B located at the upper end are called upper recesses 56A and 56B, and the recesses 56C and 56D located at the lower end are called lower recesses 56C and 56D. These roles will be described later.
Although the base 5C has no front side wall portion, the front end portions of the left side wall portion 53A and the right side wall portion 53B are bent inward at a right angle so that the central portion 5D is separated from the base 5C. It is designed to prevent it from coming off.
Further, a U-shaped notch 57 into which the inner needle guide portion 5E is fitted is provided at the center of the upper end of the rear side wall portion 53C.
Further, on the inner side surface of the rear side wall portion 53C, a spring fixing portion 58 (FIG. 11) for fixing one end of a coil spring (described later) is projected at the lower end of the left side position.
Further, on the inner side surface of the rear side wall portion 53C, a spring folding portion 59 is provided so as to extend from the center of the lower end to a position immediately below the notch 57 (position near the center upper end). The spring folding portion 59 is for folding back the other end of a coil spring (not shown) whose one end is fixed to the spring fixing portion 58. Although the coil spring will be described in detail later, only the outer needle is pulled back into the drug solution administration device 1 after puncturing a puncture needle composed of a metal outer needle and a resin inner needle into the body of the user. belongs to.
As shown in FIG. 10, the center portion 5D is fixed to the lower end of the shaft 60 of the pushing portion 5A, and the inside of the base 5C is vertically moved along the guide grooves 55A and 55B by pushing the pushing portion 5A. It can slide.
In addition, the pushing portion 5A is provided with a button 61 on the upper end of the shaft 60 in a shape that is easy to push with a finger (for example, a substantially disc shape having the same size as the belly of the finger).
Further, as will be described in detail later, a part of the central portion 5D is an outer needle 62 of a puncture needle.
As shown in FIGS. 10 and 12, the inner needle guide portion 5 </ b> E includes a substantially columnar guide portion 63 that extends in the front-rear direction, and a plate that protrudes slightly forward from the center of the lower surface of the guide portion 63. It is comprised with the support part 64 of a shape.
The guide part 63 is provided with a passage 65 extending in the front-rear direction. Further, the guide portion 63 has a shape in which the front end portion of the lower surface is bent downward, and a downward opening 66 connected to the passage 65 is provided in front of the bent portion. Furthermore, the guide part 63 is provided with a rearward opening 67 connected to the passage 65 on the rear surface.
Here, the front opening 66 is referred to as a front opening 66, and the rear opening 67 is referred to as a rear opening 67.
The inner needle guide portion 5E is fitted to the notch 57 of the base 5C with the front end portion of the guide portion 63 protruding forward from the rear side wall portion 53C of the base 5C. Attached to.
At this time, the support portion 64 of the inner needle guide portion 5E comes into contact with the outer surface of the rear side wall portion 53C of the base 5C, thereby supporting the guide portion 63 so as to be orthogonal to the rear side wall portion 53C. To do.
Further, when the inner needle guide portion 5E is attached to the base 5C in this way, the front side opening 66 is positioned in front of the rear side wall portion 53C and the outer needle 62 of the center portion 5D attached to the base 5C. It is designed to be located directly above.
The passage 65 of the inner needle guide portion 5E has a linear shape in a portion from the rear opening 67 to the vicinity of the front end, and a curved portion in which a portion from the front opening 66 ahead to the front opening 66 is curved and curved downward. Yes.
The passage 65 includes a front passage 68 which is a front portion from the center and a rear passage 69 which is a rear portion from the center. The rear passage 69 is a single passage, whereas the front passage 68 is a front portion. The passage 68 is divided into two upper and lower passages 68A and 68B.
Here, the upper passage 68A of the front passage 68 is referred to as an upper passage 68A, and the lower passage 68B is referred to as a lower passage 68B. These upper and lower passages 68 </ b> A and 68 </ b> B have leading ends connected to the front opening 66 and rear ends connected to the rear passage 69.
Of these, the upper passage 68A is a passage through which the inner needle 50 passes and is thicker than the lower passage 68B.
The inner needle 50 passes through the rear passage 69 and the upper passage 68A, is bent downward at the front end of the upper passage 68A, extends downward from the front opening 66, and is inserted into the outer needle 62 in the center portion 5D. It has become.
Further, in this passage 65, there is provided a slide portion 70 that can slide in the rear passage 69 and connects and fixes the rear end of the inner needle 50 and the front end of the delivery pipe 7B connected to the drug solution storage portion 6. It has been.
Actually, when the slide portion 70 slides forward in the rear passage 69 of the inner needle guide portion 5E, the inner needle 50 moves forward in the passage 65 and is pushed downward from the front opening 66. It is like that.
In addition, when the front end of the slide portion 70 comes into contact with the rear end of the boundary portion 71 between the upper passage 68A and the lower passage 68B, the slide portion 70 cannot slide further forward.
That is, the rear end of the boundary portion 71 functions as a stopper that restricts sliding of the slide portion 70, and this portion is hereinafter referred to as a slide stopper 71.
Furthermore, the rear end of the belt portion 72 made of a metal or resin belt is fixed to the lower end of the slide portion 70.
The belt portion 72 passes through the rear passage 69 and the lower passage 68B, is bent downward at the front end of the lower passage 68B and extends downward from the front opening 66, and the tip thereof is fixed to the center portion 5D. .
The center portion 5D and the slide portion 70 are connected by the belt portion 72, so that the slide portion 70 slides in conjunction with the slide of the center portion 5D.
Actually, when the center portion 5D slides downward by the pushing operation on the pushing portion 5A, the slide portion 70 is slid forward by the belt portion 72, and the inner needle 50 also moves.
As described above, the belt portion 72 and the slide portion 70 function as the inner needle pulling portion 73 that pulls the inner needle 50 along with the sliding of the central portion 5D by the pressing operation with respect to the pressing portion 5A.
As a result, when the center portion 5D slides downward, the outer needle 62 which is a part of the center portion 5D and the inner needle 50 whose tip is inserted into the outer needle 62 move together.
In addition, the inner needle guide part 5E can remove a part of the side surface, and the inside can be easily confirmed by removing this part.
The inner needle 50 has a tubular shape in which a portion on the rear end side of a portion inserted into the outer needle 62 of the center portion 5D can be inserted into the upper passage 68A and has an inner diameter larger than the outer diameter of the inner needle 50. It is also inserted into the inner needle bending prevention portion 74.
The inner needle bending prevention portion 74, which will be described in detail later, is a resin member that prevents the inner needle 50 from bending between the center portion 5D and the front opening 66 of the inner needle guide portion 5E. It has become.
As shown by a dotted line in FIG. 9, the lid 5F has a substantially rectangular plate shape covering the upper end of the base 5C, and a hole 75 through which the shaft 60 of the push-in part 5A passes is provided at a position near the center front end. Yes.
Further, the lid portion 5F is provided with plate-like projections 76A and 76B projecting downward at the left and right ends, respectively.
The lid portion 5F passes the shaft 60 of the push-in portion 5A through the hole 75, and the two left and right projections 76A and 76B are provided on the upper side of the left side wall portions 53A and 53B of the base 5C. By being fitted into the mating grooves 54C and 54D, it is fixed to the upper end of the base 5C.
The lid portion 5F may be provided separately from the upper housing portion 3 of the drug solution administration device 1 and fixed inside the front end side of the upper housing portion 3. It may be provided integrally with the body part 3.
The puncture mechanism 5 has such a configuration. Here, the central portion 5D will be described in more detail.
As shown in FIG. 13, the center portion 5D is mainly fixed to the outer needle slide portion 80 having the outer needle 62 of the puncture needle, and the shaft 60 of the push portion 5A, and further, the push portion 5A and the outer needle slide portion 80 And a slide fixing / releasing portion 81 for fixing or releasing the fixing.
The outer needle slide portion 80 is stacked on the slide fixing / releasing portion 81. The outer needle slide portion 80 has a substantially square U shape with the front side opened to the rear and the rear side opened rearward. Each part has a shape extending upward.
As for this outer needle slide part 80, convex part 82A and 82B are formed in the right-and-left both side surface part of the rear side.
Each of the convex portions 82A and 82B is a portion fitted into the guide grooves 55A and 55B of the base 5C, whereby the outer needle slide portion 80 slides up and down along the guide grooves 55A and 55B of the base 5C. It can be done.
Further, when the outer needle slide portion 80 is overlaid on the slide fixing / releasing portion 81, an arc-shaped recess 83 is provided at the center of the front end so as not to interfere with the shaft 60 of the pushing portion 5A.
Further, the outer needle slide portion 80 is provided with a cylindrical projection 84 projecting downward at the center of the bottom surface, which is thicker than the outer needle 62 and has the same diameter as the communication hole 51 of the fixed plate portion 5B.
A metal outer needle 62 extends downward from the lower end of the protrusion 84. The outer needle 62 is a hollow tubular needle having a length of 8 mm, an outer diameter of 0.4 mm, and an inner diameter of 0.2 mm.
Further, the outer needle slide portion 80 is provided with a plate-like protrusion 85 having a lower protruding amount than the protrusion 84 on the right side of the protrusion 84.
The protrusion 84 at the center of the bottom surface is referred to as a center protrusion 84, and the protrusion 85 located on the right side of the center protrusion 84 is referred to as a right protrusion 85.
A recess 86 is provided at the center of the upper surface of the outer needle slide portion 80, and a communication hole 87 that reaches the lower end of the central projection 84 and communicates with the outer needle 62 is provided at the center of the recess 86.
The inner needle 50 extending downward from the front opening 66 of the inner needle guide portion 5E is inserted into the outer needle 62 through the communication hole 87.
Further, the tip of the inner needle bending prevention portion 74 is attached to the recess 86. As a result, the inner needle 50 is inserted into the inner needle bending prevention portion 74 at a portion on the rear end side from the portion inserted into the outer needle 62.
The outer needle slide portion 80 configured as described above can slide in the vertical direction on the inner side of the base 5C between the inner needle guide portion 5E attached to the upper end of the base 5C and the fixed plate portion 5B. ing.
Actually, when the outer needle slide portion 80 is located at the uppermost position, the left and right side surfaces of the front end portion of the inner needle guide portion 5E are sandwiched between the left and right side surface portions on the rear side, and the front side of the inner needle guide portion 5E. A communication hole 87 is located immediately below the opening 66.
At this time, the inner needle bending prevention portion 74 is almost entirely contained in the upper passage 68A of the inner needle guide portion 5E.
Further, when the outer needle slide portion 80 is located at the lowermost position, the right projection 85 on the bottom surface abuts on the top surface of the fixed plate portion 5B, and the central projection 84 is formed in the communication hole 51 of the fixed plate portion 5B. Insert.
At this time, the central protrusion 84 does not protrude downward from the communication hole 51, and only the outer needle 62 protrudes from the communication hole 51.
At this time, the inner needle bending prevention portion 74 has a rear end portion left at the front end portion in the upper passage 68A of the inner needle guide portion 5E, and the remaining portion is exposed outside the upper passage 68A.
On the other hand, the slide fixing / releasing portion 81 is made of an elastic member, and includes a rectangular plate-shaped base 88 and U-shaped claw-shaped stoppers 89A and 89B formed at the front ends of both the left and right sides of the base 88. The shaft 60 of the pushing portion 5 </ b> A is fixed to the center of the front end of the base portion 88.
Further, the tip of the belt portion 72 of the inner needle pulling portion 73 described above is fixed to the rear end of the base portion 88.
In this way, the base 88 of the slide fixing / releasing part 81 is fixed to the pushing part 5A and the inner needle pulling part 73. That is, the pushing portion 5A and the inner needle pulling portion 73 are fixed through the slide fixing / releasing portion 81.
Further, the base portion 88 is provided with a through-hole 90 penetrating in the vertical direction for passing the central protrusion 84 of the outer needle slide portion 80 and the outer needle 62 at a position near the rear end.
On the other hand, the left and right claw-shaped stoppers 89A and 89B are respectively composed of a lower claw portion 91, a center portion 92, and an upper claw portion 93, and the lower claw portion 91 extends from the side surface of the base portion 88 and the base portion 88. It is integrally molded. The base 88, the claw-shaped stoppers 89A and 89B, and the shaft 60 of the pushing portion 5A may be integrally molded.
The left and right claw-shaped stoppers 89A and 89B are normally arranged such that the tip of the upper claw portion 93 is positioned outward from the tip of the lower claw portion 91. When added, the tip of each upper claw part 93 is deformed so as to approach each other.
Also, the left and right claw-shaped stoppers 89A and 89B are elastic members, so that when the inner pressing force disappears, the upper claw portions 93 are deformed so as to move away from each other and return to their original shapes. Yes.
The left and right claw-shaped stoppers 89A and 89B are deformed in the direction in which the upper claw portion 93 is brought closer, the claw-shaped stoppers 89A and 89B are closed, and the claw-shaped stoppers 89A and 89B are deformed in the away direction. Let it open.
When the claw-shaped stoppers 89A and 89B are closed, the upper claw portion 93 is positioned above the upper surface of the base portion 88 by a predetermined length.
Here, it is assumed that the central protrusion 84 of the outer needle slide portion 80 is fitted into the communication hole 87 of the slide fixing / releasing portion 81 and the outer needle slide portion 80 is overlapped on the slide fixing / releasing portion 81.
Here, the thickness of the slide fixing / releasing portion 81 is formed to be thinner than the protruding amount of the central protruding portion 84 of the outer needle slide portion 80, so that the tip of the central protruding portion 84 when overlapped is formed. The part projects together with the outer needle 62 downward from the through hole 90 of the slide fixing / releasing part 81.
The tip end portion of the central projecting portion 84 projecting downward is a portion to be fitted into the communication hole 51 of the fixed plate portion 5B.
Further, when the left and right claw-shaped stoppers 89A and 89B are closed in the state where the outer needle slide part 80 is overlapped on the slide fixing / releasing part 81 as described above, the upper claw parts of the left and right claw-shaped stoppers 89A and 89B are closed. The outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81 by the outer needle slide portion 80 being sandwiched between 93 and the upper surface of the base 88.
In this way, the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81. Here, since the slide fixing / releasing portion 81 is also fixed to the pushing portion 5A, the fact that the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81 means that the slide fixing / releasing portion 81 is fixed. It means that 5 A of pushing parts and the outer needle slide part 80 are fixed via.
Further, when the left and right claw-shaped stoppers 89A and 89B are opened from this state, the fixation between the slide fixing / releasing portion 81 and the outer needle slide portion 80 is released (that is, the pressing portion 5A and the outer needle slide portion 80 are fixed to each other). Is fixed).
The central portion 5D configured as described above is configured such that the outer needle slide portion 80 is overlaid on the slide fixing / releasing portion 81, and the inner needle 50 is inserted into the outer needle 62 of the outer needle slide portion 80, and the base 5C. By fitting the convex portions 82A and 82B of the outer needle slide portion 80 into the inner guide grooves 55A and 55B, the guide grooves 55A and 55B are fitted inside the base 5C.
As shown in FIG. 14A, the center portion 5D is disposed at the inner upper end of the base 5C as an initial position. In FIG. 14, for convenience of explanation, a part of the puncture mechanism 5 (button 61, coil spring, etc.) is omitted.
At this time, the center portion 5D has the inner needle 50 bent downward by the inner needle guide portion 5E, with the communication hole 87 of the outer needle slide portion 80 positioned immediately below the front opening 66 of the inner needle guide portion 5E. Is inserted into the outer needle 62 through the communication hole 87.
At this time, the entire outer needle 62 is housed in the drug solution administration device 1, while the protruding amount of the push-in portion 5A from the drug solution administration device 1 is maximized.
Further, at this time, the center portion 5D is located at the upper ends of the left side wall portion 53A and the right side wall portion 53B of the base 5C, and as shown in FIG. 15 (A), outside the left and right claw-shaped stoppers 89A and 89B. Since the upper recesses 56A and 56B serving as open spaces are positioned, the left and right claw-shaped stoppers 89A and 89B are open as shown in FIG. 14B. In FIG. 15, for convenience of explanation, a part of the puncture mechanism 5 (such as the pushing portion 5 </ b> A) is omitted and the shape of the outer needle slide portion 80 is deformed.
That is, when the center portion 5D is at the initial position, the outer needle slide portion 80 is not yet fixed to the slide fixing / releasing portion 81.
Further, when in this initial position, the outer needle slide portion 80 of the center portion 5D is positioned in front of the upper end of the spring folding portion 59 provided on the rear side wall portion 53C of the base 5C, as shown in FIG. It is supposed to be.
Here, the coil spring 94 having one end fixed to the spring fixing portion 58 provided at the lower left end of the rear side wall portion 53C of the base 5C is bent downward by the spring folding portion 59 into a J-shape. In this state, the other end is fixed to a predetermined position on the right side of the rear portion of the outer needle slide portion 80.
At this time, the coil spring 94 is in a natural length state that does not expand and contract. Then, from this state, it is assumed that the user pushes the pushing portion 5A into the drug solution administration device 1.
Then, at the center portion 5D, first, the left and right claw-shaped stoppers 89A and 89B of the slide fixing / releasing portion 81 are released from the upper concave portions 56A and 56B of the base 5C and are pressed inward by the left side wall portion 53A and the right side wall portion 53B. To close.
As a result, the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81, and the center portion 5D slides downward inside the base 5C as shown in FIG. 15B in this state. Go.
At this time, as the outer needle slide portion 80 of the central portion 5D slides downward, the entire coil spring 94 is extended so as to be deformed from the J shape to the U shape. Yes.
[6. Operation of puncture mechanism)
Here, the operation of the puncture mechanism 5 when actually puncturing the outer needle 62 and the inner needle 50, which are puncture needles, into the user's body will be described in detail.
First, as shown in FIG. 14A, the puncture mechanism 5 has the center portion 5D set at the initial position, the entire outer needle 62 is accommodated in the drug solution administration device 1, and the pushing portion 5A. The amount of protrusion from the liquid medicine administration device 1 is the maximum.
At this time, as shown in FIG. 15A, the center portion 5D has an upper recessed portion 56A provided at the upper ends of the left wall portion 53A and the right wall portion 53B on the outside of the left and right claw-shaped stoppers 89A and 89B. 14B, the left and right claw-shaped stoppers 89A and 89B are open, and the outer needle slide part 80 is not fixed to the slide fixing / releasing part 81.
Further, at this time, as shown in FIG. 19A, the inner needle 50 has its distal end kept substantially at the same position as the distal end of the outer needle 62 and does not protrude from the distal end of the outer needle 62. Is inserted inside.
Here, after the user attaches the drug solution administration device 1 to a predetermined position of the body, the pusher 5A is pushed into the drug solution administration device 1.
Then, as shown in FIGS. 15B and 16A, the central portion 5D slides downward inside the base 5C. Here, the left and right claw-shaped stoppers 89A and 89B are removed from the upper concave portions 56A and 56B, so that there is no space to open to the outside, and the left and right claw-shaped stoppers 89A and 89B are closed by being pressed inward by the left wall portion 53A and the right wall portion 53B.
As a result, as shown in FIG. 16B, the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81, and the pushing portion 5A and the outer needle slide portion 80 are fixed. Thereafter, the outer needle slide portion 80 slides downward together with the slide fixing / releasing portion 81 as the push portion 5A is pushed.
Thus, the center portion 5D is provided at the initial position without fixing the outer needle slide portion 80 to the slide fixing / releasing portion 81, and when the pushing portion 5A is pushed in, first, the claw-like shape of the slide fixing / releasing portion 81 is provided. The stoppers 89A and 89B are closed and the outer needle slide portion 80 is fixed to the slide fixing / releasing portion 81, and then the slide is moved downward with the outer needle slide portion 80 fixed to the slide fixing / releasing portion 81. It has become.
As the central portion 5D slides downward together with the pushing portion 5A in this way, the belt portion 72 fixed to the slide fixing / releasing portion 81 of the central portion 5D is slid in the inner needle guide portion 5E. The inner needle 50 is pulled by sliding the part 70 forward.
As a result, the inner needle 50 moves with the outer needle 62 reliably while maintaining the position where the tip of the inner needle 50 is substantially the same as the tip of the outer needle 62 and does not protrude from the tip of the outer needle 62.
Further, when the central portion 5D slides downward together with the pushing portion 5A in this way, the interval between the inner needle guide portion 5E and the central portion 5D is widened, and the inner needle 50 is exposed outside the inner needle guide portion 5E within this range. Will do.
Here, in the entire inner needle 50, the portion located between the inner needle guide portion 5E and the center portion 5D may be bent along with the slide of the center portion 5D if there is nothing to guide. .
Therefore, in this puncture mechanism 5 according to the present embodiment, this portion is protected by being inserted into the inner needle bending prevention portion 74.
In other words, the inner needle bending prevention portion 74 is configured to guide a portion of the entire inner needle 50 located between the inner needle guide portion 5E and the central portion 5D. Is prevented from bending.
Further, while the center portion 5D slides downward together with the pushing portion 5A in this way, as shown in FIG. 15B, the coil spring 94 having the other end fixed to the outer needle slide portion 80 of the center portion 5D extends. To go.
Here, the outer needle 62 of the center portion 5D slides downward while holding the inner needle 50 inside, and protrudes from the puncture needle hole 2B through the communication hole 51 of the fixed plate portion 5B. 50 is punctured into the user's body.
Further, when the pushing portion 5A is pushed and the entire shaft 60 of the pushing portion 5A is housed in the drug solution administration device 1 as shown in FIGS. 15C and 17A, at this time, the pushing portion 5A is The portion protruding from the drug solution administration device 1 is only the button 61, and the amount of protrusion is minimized.
When the pushing portion 5A is pushed to the end in this way, the central portion 5D reaches the lower end of the base 5C at this time. At this time, the outer needle 62 and the inner needle 50, which are puncture needles, are punctured deeply into the user's body as shown in FIG. 19B. In addition, in the chemical | medical solution administration apparatus 1, the length of the part punctured in a user's body is designed so that it may be 7 mm, for example.
At this time, the lower concave portions 56C and 56D provided at the lower ends of the left side wall portions 53A and 53B are positioned outside the claw-shaped stoppers 89A and 89B of the central portion 5D, so that the claw-shaped stoppers 89A and 89B are As shown in FIG. 17B, the force that is pressed inwardly disappears and opens.
As a result, the fixation between the slide fixing / releasing part 81 and the outer needle sliding part 80 at the center part 5D is released, and the fixing between the pushing part 5A and the outer needle sliding part 80 is released.
When the fixation is released in this manner, the outer needle slide portion 80 slides upward as shown in FIGS. 15D, 18A and 18B by the restoring force of the coil spring 94. Return to the original position.
As a result, the entire outer needle 62 is pulled out of the user's body and stored in the drug solution administration device 1. At this time, the position of the inner needle 50 is held by the inner needle pulling portion 73 fixed to the slide fixing / releasing portion 81, so that as shown in FIG. Detained.
Further, even when the outer needle slide portion 80 slides upward in this way, at least a portion of the entire inner needle 50 located between the inner needle guide portion 5E and the center portion 5D is prevented from bending the inner needle. Covered and guided by part 74.
Thus, this portion is prevented from bending as the outer needle slide portion 80 slides.
Further, as described above, the inner needle 50 is prevented from being bent between the inner needle guide portion 5E and the outer needle slide portion 80, so that the inner needle 50 comes off from the user's body or is used. It is also possible to prevent the portion placed in the body of the person from becoming shorter. That is, it can be said that the inner needle 50 can be punctured into the user's body more reliably.
In this manner, the puncture mechanism 5 punctures the inner needle 50 together with the outer needle 62 in the user's body in accordance with the pushing operation of the pushing portion 5A, and the pushing portion 5A is moved until the center portion 5D reaches the lower end of the base 5C. When pushed, that is, when the pushing portion 5A is pushed to the end, only the outer needle 62 is pulled back while the inner needle 50 is left in the body.
In the chemical solution administration device 1, when the pushing portion 5A is pushed to the end, the button 61 of the pushing portion 5A serves as a lid of the upper housing portion 3, and packing around the shaft 60 of the pushing portion 5A (not shown). Is provided with a waterproof structure that prevents water from entering the interior.
As explained so far, when the pushing portion 5A is pushed by the user, the medicinal solution administration device 1 slides the center portion 5D having the outer needle 62 downward and is fixed to the pushing portion 5A via the center portion 5D. When the inner needle pulling portion 73 thus pulled pulls the inner needle 50, the outer needle 62 and the inner needle 50 inserted into the outer needle 62 are caused to protrude from the drug solution administration device 1, so that the user's body. Puncture into.
Then, when the pushing portion 5A is pushed to the end, the medicinal solution administration device 1 opens the claw-shaped stoppers 89A and 89B of the center portion 5D, and only the outer needle slide portion 80 of the center portion 5D is restored by the restoring force of the coil spring 94. By returning to the position, only the outer needle 62 is pulled back into the drug solution administration device 1 while the inner needle 50 is left in the body of the user.
Thereafter, the medicinal solution administration device 1 administers the medicinal solution stored in the medicinal solution storage unit 6 into the body of the user through the inner needle 50 by the delivery unit 8.
In this way, the drug solution administration device 1 uses the double needle puncture needle 50 as an indwelling needle, so that the diameter of the indwelling needle is smaller than that of a conventional puncture needle using the outer needle 62 as an indwelling needle. Can be easily reduced.
That is, the medicinal solution administration device 1 can narrow the inner needle 50 as an indwelling needle, which is a portion to be placed in the user's body, thereby reducing the burden on the user.
Incidentally, the inner needle 50 made of a resin material can be manufactured with a thin tube, and its inner diameter can be made larger than that of a metal needle having the same outer diameter.
Further, the medicinal solution administration device 1 can perform from the puncture of the puncture needle (the outer needle 62 and the inner needle 50) to the withdrawal of the outer needle 62 at a time only by pushing the pushing portion 5A.
Further, since the puncture mechanism 5 of the drug solution administration device 1 operates only by the pushing operation of the user as described above, a driving unit such as a motor is not required, the configuration can be simplified, and the size can be easily reduced.
The medicinal solution administration device 1 mainly includes functions necessary for the puncture mechanism 5 including the pushing portion 5A, the outer needle slide portion 80, the slide fixing / releasing portion 81, the inner needle pulling portion 73, and the coil spring 94 ( By realizing the puncture of the puncture needle and the return of the outer needle 62), the function required for the puncture mechanism 5 can be realized while suppressing the number of parts.
Further, when the puncture is performed, the medicinal solution administration device 1 causes the inner needle to be pulled by the inner needle pulling portion 73 fixed to the pushing portion 5A via the outer needle sliding portion 80 as the outer needle sliding portion 80 slides by pushing the pushing portion 5A. By pulling 50, the inner needle 50 can be reliably moved together with the outer needle 62.
Accordingly, for example, a situation where only the outer needle 62 moves and only the outer needle 62 is punctured into the user's body is prevented, and the inner needle 50 is reliably punctured into the user's body together with the outer needle 62. be able to.
Furthermore, when the pushing portion 5A is pushed to the end, the medicinal solution administration device 1 has a compact size with few protrusions as a whole, and improves the convenience in carrying.
[7. Electrical configuration of drug solution administration device]
As shown in FIG. 20, the chemical solution administration apparatus 1 includes a CPU (Central Processing Unit) 101, a ROM (Read Only Memory) 102, a RAM (Random Access Memory) 103, a power supply unit 104, an interface unit (I / F unit) 105. The notification unit 106 and the drive unit 9 are connected via a bus 107.
The CPU 101, ROM 102, RAM 103, power supply unit 104 and notification unit 106 are arranged on the substrate unit 10. A battery is applied to the power supply unit 104. The notification unit 106 is a speaker.
The interface unit 105 is arranged on the upper casing unit 3 or the lower casing unit 2 and is adapted with a button (not shown) for receiving a user input command.
The CPU 101 performs overall control by reading the basic program stored in the ROM 102 into the RAM 103 and executing it, and executes various processes by reading out and executing various application programs stored in the ROM 102 into the RAM 103.
When the CPU 101 administers the medicinal solution to the user, it reads out the medicinal solution administration program to the RAM 103 and executes the medicinal solution administration process. In addition, after the puncture needle is punctured into the user's skin by the puncture mechanism 5, parameters such as a dose and a dose rate input via the interface unit 105 are set.
Then, the CPU 101 controls the drive unit 9 based on the set parameters and starts administration of the drug solution.
[8. Other Embodiments]
[8-1. Other Embodiment 1]
In the above-described embodiment, the case where the present invention is applied to the drug solution administration device 1 that administers a drug solution into the user's body has been described. However, the present invention is not limited to this, and any device other than the drug solution administration device 1 may be used as long as the device is a puncture device that punctures a double puncture needle composed of an outer needle and an inner needle.
For example, you may make it apply to the sensor apparatus which inserts various sensors in a user's body, and acquires biometric information.
FIG. 21 shows the sensor device 200. This sensor device 200 has the same puncture mechanism 5 as the drug solution administration device 1, but does not have the drug solution storage unit 6, the delivery unit 8, and the drive unit 9, and instead acquires biological information from the sensor. It has a control unit 201 and a transmission unit 202 that wirelessly transmits this biological information to the outside.
As shown in FIG. 22, a sensor 203 is attached to the tip of the inner needle 50 of the sensor device 200, and the sensor 203 and the control unit 201 are electrically connected to the inner needle 50. A signal line 204 is inserted.
In the sensor device 200, the puncture mechanism 5 punctures the user's body with the outer needle 62 into which the inner needle 50 having the sensor 203 attached at the tip is inserted.
The sensor device 200 pulls only the outer needle 62 back into the sensor device 200 while the sensor 203 is left in the user's body.
Thereafter, the control unit 201 of the sensor device 200 acquires biological information obtained from the sensor 203 and wirelessly transmits the information to the outside via the transmission unit 202.
[8-2. Other Embodiment 2]
In the above-described embodiment, the puncture mechanism (outer needle 62 and inner needle 50) is punctured into the user's body by the puncture mechanism 5 shown in FIGS. 9 to 13, and only the outer needle 62 is pulled back. However, the puncture needle may be punctured and the outer needle pulled back by a puncture mechanism other than the puncture mechanism 5 shown in FIGS.
[8-3. Other Embodiment 3]
In the above-described embodiment, after the puncture needle composed of the metal outer needle 62 and the resin inner needle 50 is punctured into the body of the user, only the outer needle 62 is pulled back into the drug solution administration device 1. The coil spring 94 is used as the elastic member. However, the present invention is not limited to this, and an elastic member other than the coil spring 94 may be used as long as the elastic member functions in the same manner as the coil spring 94.
[8-4. Other Embodiment 4]
Furthermore, in the above-described embodiment, the puncture mechanism 5 is provided with the inner needle bending prevention portion 74 that covers the inner needle 50 between the central portion 5D and the front opening 66 of the inner needle guide portion 5E. Not limited to this, the puncture mechanism 5 may have a configuration in which the inner needle bending prevention portion 74 is omitted.
[8-5. Other Embodiment 5]
Further, in the above-described embodiment, the inner needle pulling portion 73 of the puncture mechanism 5 is configured by the belt-like belt portion 72 and the slide portion 70.
Instead of this, instead of the belt portion 72, for example, the inner needle pulling portion 73 may be configured by a wire portion made of a metal or resin wire and the slide portion 70.
In this case, the front end of the wire portion may be fixed to the slide fixing / releasing portion 81 and the rear end may be fixed to the slide portion 70.
Further, the present invention is not limited to this, and it can be bent freely like a belt or a wire, does not expand and contract, and the slide fixing / releasing part 81 and the slide part 70 can be connected so that their distance is always constant. Any member other than a belt or wire may be used.
 本発明は、例えば医療分野に適用することができる。 The present invention can be applied to the medical field, for example.
 1……薬液投与装置、2……下筐体部、3……上筐体部、4……貼付部、5……穿刺機構、5A……押込部、5B……固定板部、5C……ベース、5D……中心部、5E……内針ガイド部、6……薬液貯蔵部、7……流路部、8……送出部、9……駆動部、10……基板部、50……内針、62……外針、73……内針牽引部、74……内針屈曲防止部、80……外針スライド部、81……スライド固定・解除部、89A、89B……爪状ストッパ、94……コイルバネ、200……センサ装置、201……制御部、202……送信部、203……センサ、204……信号線 DESCRIPTION OF SYMBOLS 1 ... Chemical solution administration apparatus, 2 ... Lower housing | casing part, 3 ... Upper housing | casing part, 4 ... Pasting part, 5 ... Puncture mechanism, 5A ... Pushing part, 5B ... Fixing plate part, 5C ... ... base, 5D ... center part, 5E ... inner needle guide part, 6 ... chemical storage part, 7 ... flow path part, 8 ... delivery part, 9 ... drive part, 10 ... substrate part, 50 …… Inner needle, 62 …… Outer needle, 73 …… Inner needle traction part, 74 …… Inner needle bending prevention part, 80 …… Outer needle slide part, 81 …… Slide fixing / release part, 89A, 89B …… Claw-shaped stopper, 94 ... coil spring, 200 ... sensor device, 201 ... control unit, 202 ... transmission unit, 203 ... sensor, 204 ... signal line

Claims (7)

  1.  外針と当該外針内に挿入される内針との二重構造でなる穿刺針と、
     前記穿刺針を収納する筐体部と、
     前記筐体部内に設けられ、前記外針内に前記内針の先端部が挿入されている状態の前記穿刺針を前記筐体部から突出させて使用者の体内に穿刺した後、当該穿刺針の内針は体内に留置させたまま、当該穿刺針の外針のみを前記筐体部内に引き戻す穿刺機構と
     を有し、
     前記穿刺機構は、
     前記筐体部に対して押込可能な押込部と、
     前記筐体部内をスライド可能で、前記外針を有する外針スライド部と、
     前記押込部と前記外針スライド部とを固定又は固定を解除する固定解除部と、
     一端が前記筐体部に固定されると共に他端が前記外針スライド部に固定される弾性部材と、
     一端が前記押込部に固定されると共に他端が前記内針の後端部に固定され、前記押込部の押し込みにともなって前記内針を牽引する内針牽引部と
     を有し、
     前記押込部と前記外針スライド部とが前記固定解除部により固定された状態で前記押込部が押し込まれると、前記外針スライド部が一方向にスライドすると共に前記内針牽引部により前記内針が牽引されることによって、前記外針が前記内針と共に前記筐体部から突出して使用者の体内に穿刺され、さらに前記外針スライド部が所定位置までスライドすると、前記固定解除部により前記押込部と前記外針スライド部との固定が解除され、前記弾性部材により前記外針スライド部のみが他方向にスライドして、前記内針を体内に留置させたまま、前記外針のみを前記筐体部内に引き戻す
     ことを特徴とする穿刺装置。
    A puncture needle having a double structure of an outer needle and an inner needle inserted into the outer needle;
    A housing for storing the puncture needle;
    The puncture needle is provided in the housing portion and punctures into the user's body by projecting the puncture needle in a state where the distal end portion of the inner needle is inserted into the outer needle. A puncture mechanism that retracts only the outer needle of the puncture needle into the housing while the inner needle is left in the body,
    The puncture mechanism is
    A pushing portion capable of being pushed into the housing portion;
    An outer needle slide part that is slidable in the housing part and has the outer needle;
    A fixing release part for fixing or releasing the fixing of the pushing part and the outer needle slide part;
    An elastic member having one end fixed to the housing and the other end fixed to the outer needle slide;
    One end is fixed to the pushing portion and the other end is fixed to the rear end portion of the inner needle, and the inner needle pulling portion pulls the inner needle as the pushing portion is pushed.
    When the pushing portion is pushed in a state where the pushing portion and the outer needle sliding portion are fixed by the fixing release portion, the outer needle sliding portion slides in one direction and the inner needle pulling portion causes the inner needle to move. When the outer needle protrudes from the housing portion together with the inner needle and is punctured into the body of the user, and when the outer needle slide portion slides to a predetermined position, the push-out is performed by the fixing release portion. And the outer needle slide part is released, and only the outer needle slide part is slid in the other direction by the elastic member, and only the outer needle is retained in the body while the inner needle is left in the body. A puncture device characterized by being pulled back into a body part.
  2.  前記穿刺機構は、
     前記内針を挿入可能で、前記内針の屈曲を防止する管状の内針屈曲防止部を有し、
     前記内針は、
     前記外針に挿入されている部分より後端側の部分が、前記内針屈曲防止部内に挿入されている
     ことを特徴とする請求項1に記載の穿刺装置。
    The puncture mechanism is
    The inner needle can be inserted, and has a tubular inner needle bending prevention portion for preventing the bending of the inner needle,
    The inner needle is
    The puncture device according to claim 1, wherein a portion on the rear end side of a portion inserted into the outer needle is inserted into the inner needle bending prevention portion.
  3.  前記穿刺機構は、
     前記内針をガイドする内針ガイド部を有し、
     前記内針は、
     前記内針ガイド部の内部を通り、前記内針ガイド部の先端に設けられた開口から前記内針ガイド部の外部に露出して前記外針スライド部の外針内に挿入され、さらに少なくとも前記内針ガイド部の開口と前記外針との間で前記内針ガイド部の外部に露出している部分が、前記内針屈曲防止部内に挿入されている
     ことを特徴とする請求項2に記載の穿刺装置。
    The puncture mechanism is
    An inner needle guide portion for guiding the inner needle;
    The inner needle is
    It passes through the inside of the inner needle guide part, is exposed to the outside of the inner needle guide part through an opening provided at the tip of the inner needle guide part, and is inserted into the outer needle of the outer needle slide part, and at least the The portion exposed to the outside of the inner needle guide portion between the opening of the inner needle guide portion and the outer needle is inserted into the inner needle bending prevention portion. Puncture device.
  4.  前記固定解除部は、
     一対の爪状ストッパを有し、当該一対の爪状ストッパを閉じる方向に力が加えられると、前記一対の爪状ストッパを閉じるように変形することによって、前記押込部と前記外針スライド部とを固定する一方で、前記加えられている力がなくなると前記一対の爪状ストッパを開いて元の形状に戻るように変形することによって、前記押込部と前記外針スライド部との固定を解除する
     ことを特徴とする請求項3に記載の穿刺装置。
    The fixing release part is
    A pair of claw-shaped stoppers, and when a force is applied in a direction to close the pair of claw-shaped stoppers, by deforming the pair of claw-shaped stoppers to close, the pushing portion and the outer needle slide portion, When the applied force disappears, the pair of claw-shaped stoppers are opened and deformed to return to the original shape, thereby releasing the fixing of the pushing portion and the outer needle slide portion. The puncture apparatus according to claim 3, wherein
  5.  前記外針スライド部が所定位置に到達するまでは、前記一対の爪状ストッパのそれぞれの外側に位置する壁部によって前記一対の爪状ストッパが内側に押圧されることによって、当該一対の爪状ストッパが閉じて前記押込部と前記外針スライド部とが固定され、
     前記外針スライド部が所定位置に到達すると、前記一対の爪状ストッパのそれぞれの外側に位置する壁部に、前記一対の爪状ストッパのそれぞれが開くための凹部が設けられていることによって、当該一対の爪状ストッパが開いて前記押込部と前記外針スライド部との固定が解除される
     ことを特徴とする請求項4に記載の穿刺装置。
    Until the outer needle slide portion reaches a predetermined position, the pair of claw-shaped stoppers are pressed inward by the wall portions positioned on the outer sides of the pair of claw-shaped stoppers. The stopper is closed and the push-in part and the outer needle slide part are fixed,
    When the outer needle slide portion reaches a predetermined position, the wall portion located outside each of the pair of claw-shaped stoppers is provided with a recess for opening each of the pair of claw-shaped stoppers, The puncture apparatus according to claim 4, wherein the pair of claw-shaped stoppers are opened to release the fixation between the push-in portion and the outer needle slide portion.
  6.  前記穿刺針の内針の先端に取り付けられたセンサと、
     前記内針を介して前記センサと接続され、当該センサからの生体情報を取得する制御部と
     を有し、
     前記穿刺機構は、
     前記外針内に前記センサが取り付けられた内針が挿入されている状態の前記穿刺針を前記筐体部から突出させて使用者の体内に穿刺した後、当該穿刺針の外針のみを前記筐体部内に引き戻すことによって、前記センサを体内に留置する
     請求項1に記載の穿刺装置。
    A sensor attached to the tip of the inner needle of the puncture needle;
    A controller that is connected to the sensor via the inner needle and acquires biological information from the sensor;
    The puncture mechanism is
    The puncture needle in a state where the inner needle with the sensor attached is inserted into the outer needle is projected from the housing portion and punctured into the body of the user, and then only the outer needle of the puncture needle is The puncture device according to claim 1, wherein the sensor is indwelled in the body by being pulled back into the housing.
  7.  外針と当該外針内に挿入される内針との二重構造でなる穿刺針と、
     前記穿刺針を収納する筐体部と、
     前記筐体部内に設けられ、前記外針内に前記内針の先端部が挿入されている状態の前記穿刺針を前記筐体部から突出させて使用者の体内に穿刺した後、当該穿刺針の内針は体内に留置させたまま、当該穿刺針の外針のみを前記筐体部内に引き戻す穿刺機構と
     薬液を貯蔵する薬液貯蔵部と、
     前記薬液貯蔵部に貯蔵された薬液を体内に留置させた前記内針を介して体内に送出する送出部と
     を有し、
     前記穿刺機構は、
     前記筐体部に対して押込可能な押込部と、
     前記筐体部内をスライド可能で、前記外針を有する外針スライド部と、
     前記押込部と前記外針スライド部とを固定又は固定を解除する固定解除部と、
     一端が前記筐体部に固定されると共に他端が前記外針スライド部に固定される弾性部材と、
     一端が前記押込部に固定されると共に他端が前記内針の後端部に固定され、前記押込部の押し込みにともなって前記内針を牽引する内針牽引部と
     を有し、
     前記押込部と前記外針スライド部とが前記固定解除部により固定された状態で前記押込部が押し込まれると、前記外針スライド部が一方向にスライドすると共に前記内針牽引部により前記内針が牽引されることによって、前記外針が前記内針と共に前記筐体部から突出して使用者の体内に穿刺され、さらに前記外針スライド部が所定位置までスライドすると、前記固定解除部により前記押込部と前記外針スライド部との固定が解除され、前記弾性部材により前記外針スライド部のみが他方向にスライドして、前記内針を体内に留置させたまま、前記外針のみを前記筐体部内に引き戻す
     ことを特徴とする薬液投与装置。
    A puncture needle having a double structure of an outer needle and an inner needle inserted into the outer needle;
    A housing for storing the puncture needle;
    The puncture needle is provided in the housing portion and punctures into the user's body by projecting the puncture needle in a state where the distal end portion of the inner needle is inserted into the outer needle. A puncture mechanism that retracts only the outer needle of the puncture needle into the housing while the inner needle is left in the body, a chemical solution storage unit that stores the chemical solution,
    A delivery section for delivering the medicinal solution stored in the medicinal solution storage section into the body through the inner needle indwelled in the body,
    The puncture mechanism is
    A pushing portion capable of being pushed into the housing portion;
    An outer needle slide part that is slidable in the housing part and has the outer needle;
    A fixing release part for fixing or releasing the fixing of the pushing part and the outer needle slide part;
    An elastic member having one end fixed to the housing and the other end fixed to the outer needle slide;
    One end is fixed to the pushing portion and the other end is fixed to the rear end portion of the inner needle, and the inner needle pulling portion pulls the inner needle as the pushing portion is pushed.
    When the pushing portion is pushed in a state where the pushing portion and the outer needle sliding portion are fixed by the fixing release portion, the outer needle sliding portion slides in one direction and the inner needle pulling portion causes the inner needle to move. When the outer needle protrudes from the housing portion together with the inner needle and is punctured into the body of the user, and when the outer needle slide portion slides to a predetermined position, the push-out is performed by the fixing release portion. And the outer needle slide part is released, and only the outer needle slide part is slid in the other direction by the elastic member, and only the outer needle is retained in the body while the inner needle is left in the body. A drug administration device characterized by being pulled back into the body.
PCT/JP2012/075874 2012-09-28 2012-09-28 Puncture device and medical fluid application device WO2014049887A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/075874 WO2014049887A1 (en) 2012-09-28 2012-09-28 Puncture device and medical fluid application device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2012/075874 WO2014049887A1 (en) 2012-09-28 2012-09-28 Puncture device and medical fluid application device

Publications (1)

Publication Number Publication Date
WO2014049887A1 true WO2014049887A1 (en) 2014-04-03

Family

ID=50387345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/075874 WO2014049887A1 (en) 2012-09-28 2012-09-28 Puncture device and medical fluid application device

Country Status (1)

Country Link
WO (1) WO2014049887A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112915376A (en) * 2019-12-05 2021-06-08 贺利氏医疗有限公司 Device for topical administration of pharmaceutical fluids

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009545341A (en) * 2006-08-02 2009-12-24 ウノメディカル アクティーゼルスカブ Cannula and delivery device
US20100331824A1 (en) * 2006-08-23 2010-12-30 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009545341A (en) * 2006-08-02 2009-12-24 ウノメディカル アクティーゼルスカブ Cannula and delivery device
US20100331824A1 (en) * 2006-08-23 2010-12-30 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112915376A (en) * 2019-12-05 2021-06-08 贺利氏医疗有限公司 Device for topical administration of pharmaceutical fluids
EP3831426A1 (en) * 2019-12-05 2021-06-09 Heraeus Medical GmbH Device for local application of pharmaceutical fluids
JP2021087783A (en) * 2019-12-05 2021-06-10 ヘレーウス メディカル ゲゼルシャフト ミット ベシュレンクテル ハフツングHeraeus Medical GmbH Device for local administration of medicine fluid
JP7026760B2 (en) 2019-12-05 2022-02-28 ヘレーウス メディカル ゲゼルシャフト ミット ベシュレンクテル ハフツング Equipment for local administration of drug fluid
CN112915376B (en) * 2019-12-05 2023-10-10 贺利氏医疗有限公司 Device for topical administration of pharmaceutical fluids

Similar Documents

Publication Publication Date Title
JP6051204B2 (en) Puncture device and drug solution administration device
JP6023816B2 (en) Puncture device and drug solution administration device
US20240108801A1 (en) Fluid Delivery Device
US20230233758A1 (en) Fluid Delivery Device Having an Insertable Prefilled Cartridge
JP6618928B2 (en) Catheter insertion device and method for inserting catheter
RU2686296C2 (en) Cartridge insert mechanism for fluid media delivery device
JP2016073722A (en) Drug delivery device
JP2010502365A (en) Disposable injection device with automatic unlocking mechanism
JP2009538692A (en) Disposable infusion device with drug level indicator
KR20120054598A (en) Inserter device with horizontal moving part
US11547796B2 (en) Medical device for transcutaneously inserting a cannula into a body tissue
KR20210016519A (en) Intranasal drug delivery devices, systems and processes
JP2021532871A (en) Needle insertion and retreat mechanism
WO2014049887A1 (en) Puncture device and medical fluid application device
JP2011250867A (en) Portable chemical pump
RU2798901C2 (en) Medical device for percutaneous cannula insert in body tissue
CN219896646U (en) Device for delivering fluid
JP2019154982A (en) Medicine administration device
JP2013192853A (en) Liquid medicine administration apparatus
JP2013192852A (en) Liquid medicine administration apparatus
JP2013192851A (en) Medicine solution administration apparatus

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12885608

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12885608

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP